CURRICULUM
VITAE
WAYNE JOHN G. HELLSTROM, M.D.
Tulane University Medical
Center
Department of Urology
1430 Tulane Avenue, SL-42
New Orleans, LA 70112-2632
Telephone: (504) 587-7308 -
Fax: (504) 588-5059
E-mail:
whellst@tmcpop.tmc.tulane.edu
ABOUT MY PRACTICE: Dr. Hellstrom is a Board Certified Urologist
and is Chief Specialist in Male Impotence and Infertility.
EDUCATION:
o
B.SC.
Physiology, McGill University, Montreal, P.Q. Canada, 1977
o
M.D.C.M.
McGill Medical School, Montreal, P.Q. Canada, 1981
o
Internship: General Surgery, Montreal
General and Royal Victoria Hospital, McGill University, Montreal, P.Q. Canada,
1981-1982
o
Residency: General Surgery, Montreal
General and Royal Victoria Hospital, McGill University, Montreal, P.Q. Canada,
1981-1983
o
Urology,
University of California, San Francisco, California, 1983-1985
o
Chief
Resident, Urology, University of California, San Francisco, 1985-1986
o
Fellowship: Andrology, University of
California, Davis, California, 1986-1988
CERTIFICATION:
Board of Medical
Examiners, State of California #G49763, 1983
Drug Enforcement
Administrative Reg. #AH3077193, 1983
Certification
for Lithotripsy, AUA(UCSF), 1986
Certification
for American Board of Urology, 1988; Recertification 1997
Louisiana State
Board of Medical Examiners Cert. #07721R, 1988
Fellow of the
American College of Surgeons, 1990
ESWL/Medstone
Training Certificate, 1996
ACADEMIC POSITIONS HELD:
o
Instructor,
Department of Urology, University of California, Davis, California, 1986 - 1988
o
Assistant
Professor of Urology, Tulane University School of Medicine, New Orleans,
Louisiana, 1988 - 1992
o
Chief,
Male Infertility and Sexual Dysfunction, Tulane University Medical Center, New
Orleans, Louisiana, 1988 - Present
o
Chief,
Section of Urology, Charity Hospital of New Orleans, New Orleans, Louisiana,
1989 - Present
o
Research
Affiliate, Delta Regional Primate Research Center, Covington, Louisiana, 1989 -
1998
o
Associate
Professor of Urology, Tulane University School of Medicine, New Orleans, Louisiana,
1992 - 1999
o
Professor
of Urology, Tulane University School of Medicine, New Orleans, Louisiana, 1999
- present
HOSPITAL AFFILIATIONS:
Tulane
University Hospital, New Orleans, Louisiana
Veterans
Administration Medical Center, New Orleans, LA
Charity Hospital
at New Orleans, New Orleans, Louisiana
Touro Infirmary,
New Orleans, Louisiana
Doctors Hospital
of Jefferson, Metairie, Louisiana
Huey P. Long
Regional Medical Center, Pineville, LA
Lakeland
Hospital, New Orleans, Louisiana
Pendleton
Memorial Methodist Hospital, New Orleans, LA
Veterans
Administration Medical Center, Alexandria, LA
Children’s
Hospital, New Orleans, Louisiana
Columbia
Lakeview Regional Medical Center, Covington, LA
Columbia
Lakeside Medical Center, Metairie, LA
University
Hospital, New Orleans, LA
RESEARCH INTERESTS:
Male infertility
Erectile
dysfunction
Sperm
stimulation protocols for improving motion parameters of sperm
Development of
new pharmacological vasoactive erection drugs in animal models
Peyronie’s
disease/reactive oxygen species/molecular aspects
RESEARCH SUPPORT:
Merck, Sharp,
& Dohme - Principal investigator, Dec. 1989 - Feb. 1991, $80,000.00. Double blind controlled study on the effects
of PROSCAR on semen analysis parameters in normal volunteers.
Mentor Corporation
- Educational grants for alpha-1 inflatable penile prosthesis study: $5,500 (1990)
National
Pharmacotherapy Institute - chaired program entitled What's New in Urology;
$4,000 (11/16/90)
BRSG - Principal
investigator; Jan. - Nov. 1991; $7,471; Development of the cat model for
characterization of erectile response to different pharmacologic agents.
Merck Sharp
& Dohme Laboratories - Co-investigator; 1992, $39,750. G.H. Besselar Associates Study: A double-blind, randomized
placebo-controlled, multi-center study to investigate the long-term effects of
Finasteride (MK-906) in patients with benign prostatic hyperplasia.
Sterling
Winthrop, Inc. - Co-investigator; 1992, $49,775. A Phase II dose ranging
efficacy study of oral Zanoterone, a new steroidal androgen receptor
antagonist, in men with symptomatic benign prostatic hyperplasia.
Roberts
Laboratories - Co-investigator; 1992, $35,432.
An open controlled study of deslorelin for the treatment of stage D2
prostate cancer.
RESEARCH SUPPORT (cont’d)
Merck Sharp
& Dohme - Principal Investigator; 1992, $45,000. MK-434 efficacy and safety study.
Merck Sharp
& Dohme - Principal Investigator, 1993, $64,000. A double-blind, placebo-controlled, multicenter study to
determine the effect of Finasteride on semen production in male volunteers.
VIVUS, Inc. -
Principal Investigator, 1993-1995, $80,000 - Clinical studies with MUSE
(Medical Urethral System for Erection); Segments I, II, III, and maintenance
study.
Merck Sharp
& Dohme - Principal Investigator, 1994, $126,051. A double-blind randomized, placebo-controlled, multicenter study
to evaluate the safety of low dose Finasteride in male volunteers.
Merck Sharp
& Dohme - Co-Investigator; 1994, $79,000.
Effect of simvastatin and pravastatin on male gonadal function. (MK-733)
Syntex -
Principal Investigator; 1994, $165,360.
A randomized double-blind placebo controlled parallel study to assess
the efficacy and safety of four oral dose levels of RS-15385-197 in men with
erectile disorder.
RD Johnson - Sub-investigator;
Protocol LOFBIV-MULTI-001, 1994 - A multicenter, open-label study to evaluate
the safety and efficacy of Levofloxacin
in the treatment of bacterial infections.
International
Medical Innovations (IMI) - Protocol #95-001; Principal Investigator; 1995,
$5,000. Dose response, efficacy and safety of an aqueous Nitroglycerin topical
cream in the treatment of impotence.
Schering -
Principal Investigator; 1996, $20,000.
Combined in-vivo and in-vitro evaluation of Interferon Alpha 2B in the
treatment of Peyronie’s disease.
TAP Holdings
Inc. - Protocol M96-470; 1996-97, $36,000.
A Phase III efficacy and safety study of Apomorphine-SL tablets for the
treatment of male erectile disorder.
Schering -
Principal Investigator; 1997, $32,000.
Combined therapy of Intralesional Interferon Alpha-2B and Vitamin E in
the treatment of Peyronie’s disease. 40
patients.
Mentor
Corporation - Principal Investigator; 1998, Protocol #820-63635-C021. Prospective study on Mentor’s Alpha-1
inflatable penile prosthesis.
VIVUS, Inc. -
Principal Investigator; 1998, Protocol AV-05:
Evaluation of the combined use of MUSE (Alprostadil) plus Actis (Venous
flow controller) in men with an unsuccessful response to MUSE therapy alone.
TAP Holdings,
Inc. - Principal Investigator; Protocol
M97-659, 1998 - $24,479. A Phase III
long-term, open-label, flexible dose, efficacy and safety study of Apomorphine
SL tablets in the treatment of male erectile dysfunction (H0260).
RESEARCH SUPPORT (cont’d)
VIVUS, Inc. -
Principal Investigator; 1998, Protocol AP-02 - Alprostadil/Prazosin CL for the
treatment of erectile dysfunction.
VIVUS, Inc. -
Principal Investigator; Protocol AP-04 - Long-term evaluation of the safety and
efficacy of transurethral
Alprostadil/Prazosin HC1 for the treatment of erectile dysfunction (H0276).
Roche Bioscience
- Principal Investigator; 1998, Protocol RO-700004S2825; 1998 - $120,347 - An
observed-blind, randomized, placebo-controlled, Latin-square extended period
study to evaluate the safety and efficacy of RO 70-0004/003, a selective alpha1A/aL
adrenoreceptor antagonist, in patients with male erectile dysfunction. October 1998
Pfizer, Inc. -
Principal Investigator; Protocol #148-109; 1999 - A double-blind, randomized,
fixed-dose, placebo controlled study to assess the efficacy and safety of
Sildenafil in preventing erectile dysfunction in patients who have undergone a
bilateral nerve sparing radical prostatectomy.
July 1999
TAP
Pharmaceuticals, Inc. - Principal Investigator, A phase III at home study
evaluating the efficacy and safety of escalating doses of Uprima 2,3,4 mg in
the treatment of erectile dysfunction.
August 1999. $32,528.
TAP Holdings,
Inc. - Principal Investigator; 1997, Protocol M97-658 - $30,341.35. Apomorphine-SL versus placebo: Phase III efficacy and safety study of four
fixed doses of Apomorphine-SL versus placebo in the treatment of male erectile
dysfunction.
PENDING:
Principal
Investigator; NIH-RO1 (1/1/00-12/31/04) - $781,122. Cellular and molecular aspects of Peyronie’s disease.
Co-Investigator;
The Center for Sexual Health (Sexual Psychophysiology Research Center). Research protocol on the etiology and
treatment of sexual dysfunction in women.
Combined therapy
of interferon alpha 2b and vitamin E in the treatment of Peyronie’s disease.
HONORS, AWARDS AND
FELLOWSHIPS:
o
University
Scholar, McGill University, 1976, 1977, 1978
o
Athlete
of the Year, McGill University, (Faculty of Medicine) 1979
o
Miley
B. Wesson Resident’s Essay Contest, Western Section of AUA (Second Prize) 1984
o
Northern
California Resident’s Seminar (Second Prize) 1985
o
James
McCarthy Essay Contest, Western Section of AUA (First Prize, co-author) 1986
o
Poster
Section, Western Section of AUA, (First Prize, co-author) 1986
o
Fellow,
Urology (Infertility), University of California, Davis (AUA Scholar) 1986,
1987, 1988
o
Miley
B. Wesson Resident’s Essay Contest, Western Section of AUA (Honorable Mention)
1987
o
Dean’s
Research Award for “The Assessment of Fertility Potential in Male Paraplegics.”
University of California, Davis (1987)
HONORS, AWARDS AND
FELLOWSHIPS
(cont’d)
o
James
McCarthy Essay Contest, Western Section of AUA (Second Prize) 1988
o
American
Urological Association, First Prize for Clinical Research (1988)
o
Resident
Presentation Contest (Co-Author), “A Modified Approach to Arterialization of
the Dorsal Vein of the Penis in Vasculogenic Impotence.” (1989)
o
Southeast
Section American Urological Association, First Place in the T. Leon Howard
Pyelogram Conference, (Co-author), “Renal Malakoplakia” (1990)
o
Round
Table Contest, Second Prize, Western Section of AUA (1990)
o
Prize
Poster, American Fertility Society:
“Absence of Short Term Gonadotoxicity in Primate Testes Receiving Shock
Wave Therapy” 1990.
o
Prize
Poster, Vth International Congress of Andrology (“Role of Platelet Activating
Factor (PAF) and Pentoxifylline (PTX) as Human Sperm Cryoprotectants”) 1993.
o
Prize
Paper, Southern Medical Association Annual Assembly, (Prophylaxis in Penile
Prosthetic Surgery) co-author. (1993)
o
Young
Andrologist Award, American Society of Andrology (1994)
o
Prize
Paper, Southern Medical Association Annual Assembly, (Stimulation of Collagen
Production in an In-Vitro Model for Peyronie’s Disease) co-author. (1994)
o
Research
Mentor for Ben Shenassa, recipient of the “Hume Award for Excellence in
Urological Research.” (1995)
o
Prize
Paper, Southern Medical Association Annual Assembly, “Testicular
Prosthesis: Pitfalls in Management of
the Testicular Mass and Testicular Trauma” (co-author). Kansas City, MO (1995)
o
Award
for Medical Excellence Scholarship Program, Southern Medical Association Annual
Assembly. Reconstruction of a Total Anterior Urethral Defect Utilizing Buccal
Mucosa”, Kansas City, MO (1995)
PROFESSIONAL SOCIETIES:
American
Fertility Society/American Society for Reproductive Medicine
American Medical
Association (1988-1994)
American Society
of Andrology
American
Urological Association
Fellow of the
American College of Surgeons
International
Society for Impotence Research
Louisiana State
Medical Society
Northern
California Association of Urologists (1983-1988)
Orleans Parish
Medical Society
Societe Internationale d'Urologie
Society of
Genitourinary Reconstructive Surgeons (GURS)
Society of Male
Reproduction and Urology
Society of
University Urologists, Inc.
Southeastern Section
of the AUA
Southern Medical
Association
EDITORSHIPS:
1988 – Present Fertility
and Sterility Journal (Reviewer)
1990 – Present Journal
of Andrology (Reviewer)
1990 – Present Assisted
Reproductive Technologies for Andrology.
ARTA (Co-editor)
1991 – Present New
England Journal of Medicine (Reviewer)
1992 – 1996 Journal
of Andrology, Editorial Board Member
1993 – Present Journal
of Urology (Reviewer)
1993 – Present Urology
(Reviewer)
1995 – Present Journal
of Clinical Investigation (Reviewer)
1995 – Present Biology
of Reproduction (Reviewer)
1997 – Present Journal
of Andrology, Associate Editor
1998 – Present Web
Site Committee (Society for the Study of Sexual Dysfunction)
EDUCATIONAL ADVISOR FOR:
o
Run Wang, M.D. - Fellowship (1990-1993); “Studies on the effects of varicocele in
primates and humans.”
o
Michelle Bell, Ph.D. Thesis (1991-1994); “Studies on membrane fluidity
and sperm capacitation of sperm.” Basic
research project was undertaken in the Andrology laboratory at TUMC.
o
Eugene Kukuy - A.F.U.D. Summer
Scholarship (1991); “The biochemical evaluation of the erectile response to
different pharmacological agents using the cat model.”
o
Joseph V. Candela - A.F.U.D. Summer
Scholarship (1992); “Penile Prosthetic Implantation: A comparison of the penile-scrotal and infra pubic surgical
approaches.”
o
Kyoko Sakamoto - A.F.U.D. Summer
Scholarship (1992); “Usefulness of Pentoxifylline stimulated cryopreserved
sperm for antisperm antibody binding in immunobead-rosette test.”
o
Kathryn Elizabeth Noles - A.F.U.D. Summer Scholarship (1993); “In-vitro studies
on collagen elaboration in the pathophysiology of Peyronie’s disease.”
o
Benham Ben Shenassa - A.F.U.D. Summer
Scholarship (1994); “Effect of papaverine, phentolamine and prostaglandin E1
triple combination on nitric oxide synthase in penile tissue.”
o
Demetrios Simopoulos - (1994); “Immunohistochemical localization of
nitric oxide synthase in penile tissue.”
o
Nikolaos Sofikitis, Ph.D. - Research Instructor (June 1994 - February 1995);
“Use of the feline model for comparison and characterization of erectile
response to different pharmacologic agents.”
o
Hunter Clay Champion - A.F.U.D.
Summer Scholarship (1995); “Investigation of adrenomedullin in the feline
erection model.”
o
Wesley W. Bryan - (1995); “Retrospective review of silastic grafts in the surgical
management of Peyronie’s disease.”
o
Lance Estrada - (1995); “Effect of cytokines on human sperm parameters.”
o
Run Wang, M.D. - Research Fellow (1993-1997); “Studies on sperm motion and
stimulation; pharmacological evaluation of penile erection in animal models.”
o
Mariano Barcelos Filho, M.D. (April 1-May 30, 1996); Visiting physician and
observer in Urology & Andrology.
o
Javier Molina, M.D. (March 1-April 20, 1997); Visiting physician and observer in Andrology
and Urology.
o
S. Bradley Pradel, M.D. - Research
Student (June 1997 - July 1997) – “Effect on pentoxifylline on human sperm
acrosome challenge (ARIC) test.”
o
Charles F. Chehardy, M.D. - Visiting Fellow (January 1998 - March 1998) –
“Effect of spinal cord injury on rat reproductive functions.”
EDUCATIONAL ADVISOR FOR (cont’d)
o
Trinity J. Bivalacqua - A.F.U.D.
Summer Scholarship (1998-pending); Graduate Student (May 1997 - 1998) – “The
effect of phosphodiesterase inhibitors on penile erection,” and “Cellular and
molecular aspects of Peyronie’s disease in a rat model.”
o
Claudio Teloken, M.D. - Visiting professor and observing urologist in the
Section of Andrology (February 1999).
o
Erik Diner, A.F.U.D. Summer
Scholarship (1999- ); “Evaluation of erectile response and nitric oxide
synthase isoforms in the Peyronie’s disease rat model.”
o
Tom Novak, A.F.U.D. Summer
Scholarship (1999- ); “Oral and intralesional therapies for Peyronie’s disease
in a rat model.”
o
Samboon Leugwattanakis, Visiting Fellow (September 1999 - until)
COMMITTEES: Intramural
University
Committees:
o
Member,
Human Subjects Review Committee, Tulane University School of Medicine, New
Orleans, 1989 - 1993.
o
Member,
Search Committee for Chairman of the Department of Obstetrics and Gynecology,
Tulane University School of Medicine, New Orleans, 1989 - 1990.
o
Faculty
Advisory Committee to the Dean, Tulane University School of Medicine, New
Orleans, 1990 - 1992.
o
Ob-Gyn
In-Depth Review Subcommittee, Tulane University School of Medicine, New
Orleans, 1994.
o
Medicine
In-Depth Review Subcommittee, Tulane University School of Medicine, New
Orleans, 1996-1997.
Hospital
Committees:
o
Member,
Outpatient Surgery Committee, Tulane University Hospital and Clinic, New
Orleans, 1989
o Member, Infection Control Committee, Tulane University Hospital and Clinic, New Orleans, 1989 - 1994
o
Member,
Executive Committee, Charity Hospital, New Orleans, 1989 - 1994
o
Member,
Quality Assurance Review Committee, Tulane University Hospital and Clinic, New
Orleans, 1990 -1994
o
Member,
Surgery Peer Review Committee, Charity Hospital, New Orleans, 1990 - Present
o
Member,
Operating Room Committee, Tulane University Hospital and Clinic, New Orleans,
LA, 1993 - 1994
o
Member,
Operating Room Committee, Tulane University Medical Center, 1996- 1999
o
Member,
Medical Staff Review Subcommittee, Tulane University Hospital and Clinic, New
Orleans, 1990 - 1994
o
Obstetrics
and Gynecology Review Committee, Tulane University Medical Center, 1998
Extramural:
o
Member,
Long-term Planning Committee, American Society of Andrology, 1992 - Present
o
Member,
Student Affairs Committee, American Society of Andrology, 1992 - 1994
o
Member,
Abstract Committee, American Fertility Society, 1993
o
Secretary,
Southern Medical Association, 1993 - 1996.
o
Executive
Member, Male Reproduction/Urology Committee, American Fertility Society, 1994 -
1996.
o
Member,
Education Policy Committee, American Society of Andrology, 1994 - 1995
o
Chairman,
Education Policy Committee, American Society of Andrology, 1995-1997
o
Member,
Industrial Relations Committee, American Society of Andrology, 1993 - 1997.
o
Member,
Auditing Committee, American Urological Association, Society for the Study of
Male Reproduction 1995
o
Member,
Impotence Guidelines Committee, American Urological Association, 1995-1996
o
Member,
USP General Committee of Revision, Expert Advisory Panel on Urology, 1995 -
2000
o
Chairman,
Symposium on Testosterone Deficiency, Southern Medical Association, 1996
o
Member,
Auditing Committee, AUA Society for the Study of Impotence Research, 1996-1997
o
Member,
American Urological Association and the American Foundation of Urologic Disease
(AUA/AFUD) Research Committee, 1996-2000
o
Vice
Chairman of Urology Section, Southern Medical Association, 1997
o
Member,
Auditing Committee, Soci?t? International Urologic, 1997-1998
o
Member,
Strategic Plan Committee - American Society of Reproductive Medicine, 1997-1999
o
Representative
of Liaison Committee; ASA/ASRM and ASBUR, 1997 - 2000
o
The
New Strategic Planning Committee for the SMRU, 1998
o
Chair,
Section of Urology, Southern Medical Association, 1998-2001
o
Member,
Society for the Study of Sexual Dysfunction Web Site Committee, 1998
o
Member,
Abstract Committee, AUA and Southeastern Section of the AUA, 1999
o
Chair,
Liaison Committee - ASA/ASRM and ASBUR,
1999 - 2000
o
Member,
Awards Committee - American Society of Andrology, 1998-2000
PUBLICATIONS IN REFERRED
JOURNALS:
Hellstrom WJG; Kogan BA; Jeffrey RB and McAninch JW: The natural history of prenatal
hydronephrosis with normal amounts of amniotic fluid. J Urology, 132:947-950,
1984.
Hellstrom WJG; Edwards MSB and Kogan
BA: Urological aspects of the tethered
cord syndrome. J Urology, 135:317-320, 1986.
Lue TF; Hellstrom
WJG; McAninch JW and Tanagho EA:
Priapism: A refined approach to
diagnosis and treatment. J Urology, 136:104-108, 1986.
Hellstrom
WJG: Subclinical genital infection and male
infertility: No link found. Urology
Times 14, 1986.
Junemann KP; Lue
TF; Abozeid M; Hellstrom WJG and Tanagho EA: Blood gas analysis in drug-induced penile erection. Urologia
Internationalis, 41:207-211, 1986.
Hellstrom
WJG: In unexplained male infertility, is
antibiotic treatment of real value? Urology Times, 14(5), 1987.
PUBLICATIONS IN REFERRED
JOURNALS
(cont’d)
Hellstrom WJG; Schacter J; Sweet RL;
McClure RD: Is there a role for chlamydia
trachomatis and genital mycoplasma in male infertility? Fertility
and Sterility, 48:337-339, 1987.
Hellstrom WJG; Schmidt RA; Lue TF and
Tanagho EA: Neuromuscular dysfunction
in nonbacterial prostatitis. Urology, 1987.
Hellstrom WJG; Deitch AD; deVere White
RA: Clinical Applications of DNA flow
cytometry of testicular aspirates in evaluating male infertility. Surgical
Forum, 38:642, 1987.
Hellstrom WJG; Overstreet JW; Moore S;
Samuels S; Chang RJ; Lewis EL:
Antisperm antibodies bind with different patterns to sperm of different
men. J Urology, 138:895, 1987.
Hellstrom
WJG: Voiding dysfunction with nonbacterial
prostatitis. Medical Aspects of Human Sexuality, 21:36, 1987.
Hellstrom
WJG: Serum immunoglobulin G antibody may indicate
immunologic infertility. Urology Times, 16(6):21, 1988.
Lewis EL, Hellstrom
WJG: Improved design for
microsurgery table. Urology, 32:452, 1988.
Hellstrom WJG; Overstreet JW; Samuels SJ;
Lewis EL: The relationship of
circulating antisperm antibodies to sperm surface antibodies in infertile
men. J Urology, 140:1039, 1988.
Narayan P;
Lillian D; Hellstrom WJG; Hedgcock M; Jajodia PB; Tanagho EA: The benefits of combining early radionuclide
renal scintigraphy with routine bone scans in patients with prostate
cancer. J Urology, 140:1448, 1988.
Hellstrom WJG; Deitch AD; deVere White
RW: Evaluation of vasovasostomy
candidates by DNA flow cytometry of testicular aspirates. Fertility
and Sterility, 51(3):546-48, 1989.
Hellstrom WJG; Stone AR; Deitch AD; deVere
White RW: The clinical application of
aspiration DNA flow cytometry to neurologically impaired men entering an
electroejaculation program. J Urology, 142:309, 1989.
Hellstrom WJG and Sikka SC: Pentoxifylline stimulates the movement
characteristics of cryopreserved sperm.
Surgical Forum, 40:648, 1989.
Hellstrom WJG; Tesluk H; Deitch AD;
deVere White RW: Comparison of flow
cytometry to routine testicular biopsy in male infertility. Urology,
35:321, 1990.
Hellstrom WJG; Samuels SJ; Waits AB;
Overstreet JW: Comparison of spermmar
and immunobead testing for IgG antisperm antibody binding. Fertility
and Sterility, 52:1027, 1990.
Hellstrom
WJG: Operating table design modifications for
urologic microsurgery. Urol Clin N Am, 17:1, 1990
PUBLICATIONS IN REFERRED
JOURNALS
(cont’d)
Hellstrom WJG and Kaack B: Optimum testicular aspiration technique for
DNA flow cytometric analysis of spermatogenesis in primates (Papio anubis). Fertility
and Sterility, 54:517, 1990.
Lapeyrolerie J;
Avant J; Malter J; Hellstrom WJG:
Standardization of fine needle aspiration biopsy of human testes using
DNA flow cytometry. Surgical Forum, 41:682, 1990.
Sikka SC and Hellstrom
WJG: Functional evaluation and
motility parameters of Pentoxifylline-stimulated cryopreserved human
sperm. Assisted Reproductive Technology/Andrology, 1:309, 1990.
Sikka SC and Hellstrom
WJG: The application of
Pentoxifylline in the stimulation of sperm motion in men undergoing
electroejaculation. J Andrology, 12:165, 1991.
Dean OJ; Hellstrom
WJG; Krane NK: Urologic prostheses
and continuous ambulatory peritoneal dialysis.
Letter to the Editor, J Urology,
145:1279, 1991.
Naftulin BN;
Samuels SJ; Hellstrom WJG; Lewis EL; Overstreet JW: Semen quality in varicocele patients is
characterized by tapering sperm cells. Fertility and Sterility, 56:149, 1991.
Salvatore FT;
Sharman GM; Hellstrom WJG:
Vacuum constriction devices (VCD) and the clinical urologist; making an
informed selection. Urology, 38:323, 1991.
Hellstrom WJG; Wang R; Sikka SC: Platelet activating factor (PAF) stimulates
motion parameters of cryopreserved human sperm. Fertility and Sterility,
56:768, 1991.
Hurwitz G;
Reimund E; Moparty KR; Hellstrom WJG:
Bilateral renal parenchymal malakoplakia: A case report. J Urology, 147:115, 1992.
Walters FP; Neal
DE; Rege AB; George WJ; Ricci MJ; Hellstrom WJG: Cavernosal tissue antibiotic levels in
penile prosthesis surgery. J Urology, 147:1282, 1992.
Bell M; Sikka
SC; Rajasekaran M; Hellstrom WJG:
Time course study of hydrogen peroxide induced changes in the lipid
peroxidation of human sperm membranes. Assisted Reproductive Technology/Andrology,
3:144, 1992.
Hellstrom
WJG: New techniques in the diagnosis and
treatment of male infertility and vasectomy reversal. Current Opinions in Urology,
2:457-462, 1992.
Lee B; Sikka SC;
Randrup ER; Villemarette P; Baum N; Hower JF; Hellstrom WJG: Standardization of penile blood flow
parameters in normal men using intracavernosal PGE1 and visual
sexual stimulation. J Urology, 149:49-52, 1993.
Rajasekaran M;
Nair AGR; Hellstrom WJG; Sikka SC:
Spermicidal activity of an antifungal saponin obtained from the tropical
herb Mollugo Pentaphylla. Contraception,
47(4):401-12, 1993.
PUBLICATIONS IN REFERRED
JOURNALS
(cont’d)
Hellstrom WJG; Kaack MB; Harrison RM;
Thomas R; Neal DE: Absence of long-term
gonadotoxicity in primates receiving extracorporeal shock-wave application. J
Endourology, 7(1):17-21, 1993.
Daroca PJ Jr.;
Martin AA; Reed RJ; Krengel SS; Hellstrom WJG: Urethral nephrogenic
adenoma. J Urologic Pathology, 1:157-72, 1993.
Weintraub MP; De
Mouy E; Hellstrom WJG: Newer
modalities in the diagnosis and treatment of ejaculatory duct obstruction. J
Urology, 150:4 1150-54, 1993.
Sikka SC; Hellstrom
WJG; Naz RK: Pentoxifylline: Role in management of male infertility and
mechanisms of action. Molecular Andrology, 5:220-231,
1993. Review Article.
Bell M; Wang R; Hellstrom
WJG; Sikka SC: Effect of
cryoprotective additives and cryopreservation protocol on sperm membrane lipid
peroxidation and recovery of motile human sperm. J Andrology
14(6):472-78, 1993.
Wang R; Higuera
TR; Sikka SC; Minkes RK; Bellan JA; Kadowitz PJ; Domer FR; Hellstrom WJG:
Penile erections induced by vasoactive intestinal peptide and sodium nitroprusside. Urol
Res. 21(1):75-8, 1993.
Wang R; Sikka
SC; Veeraragavan K; Bell M; Hellstrom WJG: Platelet activating factor and pentoxifylline as human sperm
cryoprotectants. Fertil Steril. 60(4):711-15, 1993.
Dahiya R; Sikka
SC; Hellstrom WJG; Hayware SW; Narayan P; Tanagho EA; Lue TF: Phenotypic and cytogenetic characterization
of a human corpus cavernosum cell line (DS-1).
Biochemistry and Molecular Biology
International 30:559-69, 1993.
Wang R; Steele
RH; Harrison RM; Hellstrom WJG:
Radiologic observations of long-term partial left renal vein occlusion
in the cynomolgus monkey. Infertility 16(1), 1994.
Sikka SC; Wang
R; Kukuy EL; Walker CF; Hellstrom WJG:
The detrimental effects of electric current on normal human sperm. J
Andrology 15(2):145-50, 1994.
Wang R; Domer
FR; Sikka SC; Kadowitz PJ; Hellstrom WJG: Nitric oxide mediates penile erection in cats J
Urology 151(1):234-37, 1994.
Hellstrom WJG; Candela JV; Neal DE
Jr.: Successful preservation of potency
in treatment of glans hyperemia following deep penile vein revascularization
surgery. Intl J Impotence Research 6(1):1-7, 1994.
Belker AM; Oats
RD; Hellstrom WJG, et al.
Results in the United States with sperm micro-aspiration retrieval
techniques and assisted reproductive technologies. J Urology 151:1255-59,
1994.
Hellstrom WJG; Monga M; Wang R; Domer FR;
Kadowitz PJ; Roberts JA: Penile
erection in the primate: induction with nitric-oxide donors. J
Urology, 151:1723-1727, 1994.
PUBLICATIONS IN REFERRED
JOURNALS
(cont’d)
Hellstrom WJG; Bell M; Wang R; Sikka
SC: Effect of sodium nitroprusside on
sperm motility, viability, and lipid peroxidation. Fertil Steril.
61(6):1117-22, 1994.
Wang R; Bell M; Hellstrom
WJG; Sikka SC: Post-thaw motility,
cAMP concentration and membrane lipid peroxidation after stimulation with
pentoxifylline and platelet-activating factor. Intl J Androl.
17(4):169-73, 1994.
Monga M; Wang R;
Roberts JA; Hellstrom WJG:
Tunica vaginalis sperm reservoir in a monkey model of vas deferens
obstruction. J Androl. 15(4):309-10, 1994.
Rajasekaran M; Hellstrom
WJG; Sparks RL; Sikka SC: Sperm
damaging effects of electric current: possible role of free radicals. Reproductive
Toxicology, 8(5):427-32, 1994.
Sikka SC; Wang
R; Kukuy E; Walker CF; Hellstrom WJG:
The detrimental effect of
electric current on normal human sperm.
J Androl. 15(2):145-50, 1994.
Sofikitis NV;
Miyagawa I; Agapitos E; Pasyianos P; Toda T; Hellstrom WJG; Kawamura
H: Reproductive capacity of the nucleus
of the male gamete after completion of meiosis. J Assisted Reproduction
and Genetics 11(7):335-41, 1994.
Monga M; Moreno
T; Hellstrom WJG: Gunshot wounds
to the male genitalia: management for the clinical urologist. Contemporary Urology 7(1):58-63, 1995.
Monga M; Moreno
T; Hellstrom WJG: Gunshot wounds
to the male genitalia. J Trauma 38(6):855-8, 1995.
Monga M; Puyau
FA; Hellstrom WJG: Posttraumatic
high-flow internal pudendal artery-urethral fistula. J Urology 153(3 Pt
1):734-6, 1995.
Steele RH;
Martin AA; Sikka SC; Hellstrom WJG: Penile intracavernosal substance
abuse. Urology 45(4):686-88, 1995.
Rajasekaran M; Hellstrom
WJG; Naz RK; Sikka SC: Oxidative
stress and interleukins in seminal plasma during leukocytospermia. Fertil
Steril. 64(1):166-71, 1995.
deBoisblanc MW;
Robichaux WH; Hellstrom WJG:
Large scrotal epidermal inclusion cyst and hydrocele. J La
State Med Soc. 147(6):280-1, 1995.
Hellstrom
WJG; Monga
M; Sofikitis N: Current medical
treatment of idiopathic oligozoospermia.
Jpn J Fertil Steril. 40(3):386-97, 1995.
Sofikitis N;
Miyagawa I; Dimitriadis D; Zavos P; Sikka SC; Hellstrom WJG: Effects of smoking on testicular function,
semen quality, and sperm fertilizing capacity. J Urology 154(3):1030-34,
1995.
Lowentritt JE;
Kawahara K; Human LG; Hellstrom WJG; Domingue GJ: Bacterial infection in prostatodynia. J Urology 154(4):1378-81, 1995.
PUBLICATIONS IN REFERRED
JOURNALS
(cont’d)
Hellstrom WJG; Lewis R; Narayan P: Benign prostatic hyperplasia patient
evaluation and treatment options. South Med J 5(3):7-8, 1996
Candella JV and Hellstrom
WJG: Three-piece inflatable penis
prosthesis implantation: a comparison of the penoscrotal and infrapubic
surgical approaches. J La State Med Soc. 148(7):296-301,
1996.
Monga M and Hellstrom
WJG: Medical Treatment for Male
Infertility. Contemporary Urology 8(9):23-47,
Sept. 1996.
Monga M;
Broderick GA; Hellstrom WJG:
Priapism in sickle cell disease: the case for early implantation of the
penile prosthesis. Eur Urology 30(1):54-9, 1996.
Hellstrom WJG; Monga M; Cote D; Harmon
E: Reconstruction of a total anterior
urethral defect using buccal mucosa. South Med J. 89(11):1088-91, 1996.
Hellstrom WJG; Bennett AH; Gesundheit N;
Kaiser FE; Lue TF; Padma-Nathan H; Peterson CA; Tam PY; Todd LK; Varady JC and
Place VA: A double-blind,
placebo-controlled evaluation of the erectile response to transurethral
alprostadil. Urology 48(6):851-56, 1996.
Rajasekaran M; Hellstrom
W; Sikka S: Quantitative assessment of cytokines (GRO alpha and IL-10) in
human seminal plasma during genitourinary inflammation. Am J
Reprod Immunol. 36(2):90-5, 1996.
VandenBerg TL
and Hellstrom WJG:
Individualizing androgen replacement therapy. Contemporary Urology
Supplement, p. 25-38, 1997.
Padma-Nathan H; Hellstrom
WJG; Kaiser FE; Labasky RF; Lue TF; Nolten WE; Norwood PC; Peterson, CA;
Shabsigh R; Tam PY; Place VA and Gesundheit N:
Treatment of men with erectile dysfunction with transurethral
alprostadil. Medicated urethral system
for erection (MUSE) study group. N Engl J Med. 336(1):1-7, 1997.
Ghoniem GM;
Shoukry MS; Faced AAS; Hellstrom WJG and Sakr MA: Human vasal changes
after vasectomy: In vitro studies. Eur Urology 31(2):231-36, 1997.
Champion HC;
Wang R; Shenassa BB; Murphy WA; Coy DH; Hellstrom WJG; Kadowitz PJ: Adrenomedullin induces penile erection in
the cat.
Eur J Pharmacol. 319(1):71-5, 1997.
Wood JC; Monga M
and Hellstrom WJG: Penile
Calciphylaxis. Urology 50(4):622-4, 1997.
Labadie P and Hellstrom
WJG: Hematospermia: Clinical directives. South Med J. 90(10):S127, 1997.
Champion HC;
Wang R; Santiago JA; Murphy WA; Coy DH; Kadowitz PJ and Hellstrom WJG: Comparison of responses to adrenomedullin
and calcitonin gene-related peptide in the feline erection model. J Andrology 18(5):513-21, 1997.
PUBLICATIONS IN REFERRED JOURNALS (cont’d)
Champion HC;
Wang R; Hellstrom WJ and Kadowitz PJ: Nociceptin, a novel endogenous
ligand for the ORL1 receptor, has potent erectile activity in the cat. Am J
Physiol. 273(1 Pt. 1):E214-19, 1997.
Estrada LS;
Champion HC; Wang R; Rajasekaran M; Hellstrom WJ; Aggarwal B; and Sikka
SC: Effect of tumor necrosis factor-alpha (TNF-"?) and interferon-(? (IFN-?() on human sperm motility,
viability and motion parameters. Int J Androl 20(4):237-42, 1997.
Ahuja SK; Krane
NK and Hellstrom WJ: Penile
prostheses in the management of impotence in patients with end-stage renal
disease. J La State Med Soc, 150(1):32-4, 1998.
Hellstrom WJG: Priapism: Approaches to
management. AUA News, 3(1):14-15, 1998.
Hellstrom WJG; Wang R; Peterson C; Varady
J; Gesundheit N and Sikka SC: Effects of alprostadil and prazosin on motility,
viability and membrane integrity of human sperm. J Urology, 159(5):1559-62,
1998.
Peterson CA;
Bennett AH; Hellstrom WJG; Kaiser FE; Morley JE; Nemo KJ;
Padma-Nathan H; Place VA; Prendergast
JJ; Tam PY; Tanagho EA; Todd LK; Varady JC and Gesundheit N: Erectile response
to transurethral alprostadil, prazosin and alprostadia-prazosin
combinations. J Urology, 159(5):1523-27; discussion 1527-8, 1998.
Hellstrom WJG and Domingue GJ: Bacterial
infection in prostatodynia (letter to editor: Dr. Peter M. Joseph). J
Urology, 154:1378-1381 (1995), Editor’s Letter, 1998.
Netto Jr., RR;
Esteves SC; Neves PA: Transurethral resection of partially obstructed
ejaculatory ducts: Seminal parameters and pregnancy outcomes according to the
etiology of obstruction. (Editorial
Comment: Wayne J.G. Hellstrom) J
Urology, 6(159):2048-53, 1998.
Armstrong JS;
Rajasekaran M; Hellstrom WJG and Sikka SC: Antioxidant potential of
human serum albumin: Role in the
recovery of high quality human spermatozoa for assisted reproductive
technology. J Andrology, 19(4):412-19, 1998.
Hellstrom WJG: When and how to treat the
androgen-deficient male. Contemporary Urology, 10(9): 52-68,
1998.
Lasser A;
VandenBerg TL; Vincent M and Hellstrom WJG: Intraplaque verapamil
injection for treatment of Peyronie’s disease.
J La Med Soc. 150(9):431-4,
1998.
Constabile RA;
Spevak M; Fishman IJ; Govier FE; Hellstrom WJG; Shabsigh R; Nemo KJ;
Rapport JL; Tam PY; Weldon KLM and Gesundheit N: Efficacy and safety of
transurethral alprostadil in patients with erectile dysfunction following
radical prostatectomy. J Urology 160(4):1325-8, 1998.
Bivalacqua TJ;
Rajasekaran M; Champion HC; Wang R; Sikka SC; Kadowitz PJ and Hellstrom WJG:
The influence of castration on pharmacologically induced penile erection in the
cat. J Andrology, 19(5):551-7, 1998.
PUBLICATIONS IN REFERRED
JOURNALS
(cont’d)
Domingue GJ and Hellstrom
WJG: Prostatitis. Clin Microbiol Reviews,
11(4):604-13,Review. 1998.
Rajasekaran M;
Mondal D, Agrawal K, Chen IL, Hellstrom WJG, and Sikka SC: Ex vivo expression
of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile
cavernosal cells. J Urology, 160(6 Pt. 1):2210-15, 1998.
Champion HC;
Bivalacqua TJ; Wang R; Hellstrom WJG; and Kadowitz PJ: [Tyr1]-nociceptin
and nociceptin have similar naloxone-insensitive erectile activity in the
cat. J Andrology, 19(6):747-753, 1998.
Armstrong JS;
Rajasekaran M, Chamulitrat W, Gatti P, Hellstrom WJ and Sikka SC:
Characterization of reactive oxygen species induced effects on human
spermatozoa movement and energy metabolism.
Free Radic Bio Med 26(7/8):869-80,
1999.
Labadie P and Hellstrom
WJG: Hematospermia: Diagnosis, evaluation, and clinical relevance. Contemporary
Urology 11(4):125-9, 1999.
Ahuja SK; Sikka
SC and Hellstrom WJG: Stimulation of collagen production in an in vitro
model of Peyronie’s disease. International Journal of Impotence Research
11;1-6, 1999.
Champion HC;
Bivalacqua TJ; Wang R; Kadowitz PJ; Keefer LK; Saavedra JE; Hrabie JA; Doherty
PC and Hellstrom WJG: Induction of penile erection by intracavernosal
and transurethral administration of novel nitric oxide donors in the cat. J
Urology 161:2013-19, 1999.
Ahuja SK;
Bivalacqua TJ, Case J, Vincent MJ; Sikka SC and Hellstrom WJG: A pilot
study demonstrating clinica benefit from intralesional Interferon Alpha 2b in
the treatment of Peyronie’s disease. Journal of Andrology 20:444-448, 1999
Hellstrom WJG: Testosterone Replacement Therapy. In: Digital Urology Journal, website:
http://www.dug.com/Article/Hellstrom2/Hellstrom2.html. 1999
Shenassa B and Hellstrom
WJG: Premature ejaculation: from
historical origins to current treatment.
Chronicle of Urology 7 Sexual
Medicine Augst 1999, pp. 11-12
Champion HC,
Bivalacqua TJ, Hyman AL, Ignarro LJ, Hellstrom WJG, and Kadowitz PJ: Gene-transfer of endothelial nitric oxide
synthase to the penis augments erectile responses in the aged rat. Proceedings
of the National Academy of Science Vol. 96:11648-11652 September 1999
Bivalacqua TJ;
Champion HC; Rajasekaran M; Kadowitz PJ; Sikka SC; Doherty PC and Hellstrom
WJG: Potentiation of erectile
response and cAMP accumulation by combination of prostaglandin E1 and rolipram,
a selective inhibitor of the type 4 phosphodiesterase (PDE 4). Journal
of Urology (In Press), 1999
Hellstrom WJ: Testosterone Replacement
Therapy. Digital Urology Journal (In press)
INVITED CHAPTERS AND REVIEWS:
Bivalacqua TJ;
Champion HC; Wang R; Kadowitz PJ; Doherty PC and Hellstrom WJG: Feline
penile erection induced by transurethral administration of sodium nitroprusside. Urological
Research (In press)
Bivalacqua TJ,
Champion HC, Purohit SK, Murphy WA, Coy DH, Kadowitz PJ, and Hellstrom WJG: Nitric oxide-medicated erectile effects of
galantide but not galanin in vivo. Nitric Oxide (Submitted), 1999
Hellstrom WJ: Application of Pericardial Graft in the Surgical Management of
Peyronie’s Disease. (Submitted) Journal of Urology.
Overstreet JW;
Fuh VL; Howards SS; Lieber MM; Hellstrom WJG, et al.: Chronic treatment
with finasteride 1 mg/day does not affect spermatogenesis or semen production
in young men. J Urology (Submitted), 1999
Hellstrom WJG; McAninch JW; Lue TF: Priapism:
Pathophysiology and treatment.
In R.W. deVere White (Guest Ed.)
Problems in Urology, Sexual
Dysfunction. JB Lippincott Company,
1987.
Hellstrom WJG; Overstreet JW; Lewis
EL: The clinical significance of
antibodies in the treatment of male infertility. In R.W. deVere White (Guest Ed.) Problems in Urology, Sexual Dysfunction, JB Lippincott Company,
1987.
Hellstrom
WJG: Immunologic Infertility and the Immunobead
Test. In Common Problems In Infertility,
Edited by J. Raifer and A. Wein, 1989.
Hellstrom WJG and Salvatore FT: Vacuum constriction devices: Are they useful? In World Book on Impotence
Research: Basic and Clinical. Edited by Tom Lue. pp. 169-80, 1992.
Hellstrom WJG and Neal DE: The diagnosis and therapy of male genital
tract infections. Infertility and Reproductive Medicine Clinics of North America, pp.
399-411, April 1992.
Sikka SC and Hellstrom
WJG: The application of
pentoxifylline in the stimulation of sperm motion in men undergoing
electroejaculation. Treatment of Male
Infertility in: Year Book of Infertility.
Mosby Year Book Inc., p. 133, 1992.
Hellstrom
WJG: The new injection treatment for impotence: Medical
and psychological aspects, Wagner and Kaplan. (Review) N Engl J Medicine, 329(6):439-440, 1993.
Sikka SC and Hellstrom
WJG: Vascular laboratory diagnosis
of impotence. In: The Noninvasive Vascular Laboratory: Current Issues and Clinical
Developments, editors: Auer and Neumyer, St. Louis, MO. (In press)
Wang R; Monga M;
Hellstrom WJG: Ejaculatory
Dysfunction. In: Textbook of Clinical Andrology, edited by Professor Frank Comhaire.
(1995).
Monga M and Hellstrom
WJG: Testicular Trauma In: Adolescent
Medicine: State of the Art Reviews, 1996.
INVITED CHAPTERS AND REVIEWS (cont’d)
Monga M;
Sofikitis N and Hellstrom WJG:
Benign scrotal masses in the adolescent male: Varicoceles, spermatoceles, and hydroceles. Adolescent
Medicine: State of the Art Reviews,
1996.
VandenBerg T and
Hellstrom WJG: Hormonal
evaluation and treatment of the patient with sexual dysfunction. In: The Diagnosis and Management of Male Sexual
Dysfunction Edited by John J.
Mulcahy, pgs. 35-54, 1996.
Hellstrom WJG: Surgical treatment of Peyronie's disease In: Textbook of Andrology: Relevant issues in
male infertility and sexual dysfunction.
Edited by Wayne J. G. Hellstrom.
Allen Press, Inc. Chapter 36,
1997.
Monga M and Hellstrom
WJG: Testicular Torsion and
Fertility In: Textbook of Andrology: Edited by Wayne J. G. Hellstrom. Allen Press, Inc. Chapter 22, 1997.
Monga M and Hellstrom
WJG: Cryptorchidism and Fertility
In: Textbook of Andrology: Edited by
Wayne J. G. Hellstrom. Allen Press,
Inc., Chapter 36, 1997.
Monga M and Hellstrom
WJG: Nongonococcal urethritis. In:
Conn’s Current Therapy.
Edited by Robert E. Rakel. W. B.
Saunders Company, pgs. 736-37, 1997.
Hellstrom WJG; Monga M and Sofikitis N:
Fertilidadee Infertilidade Humana: Oligospermia Idiop<tica. Edited by Claudio Tel`ken. MEDSI
Editora MJdicare Cientifica Ltda.. Chapter 41, pgs. 515-27
(1997).
Bivalacqua TJ;
Champion HC; Kadowitz PJ, Doherty PC and Hellstrom WJG: Potentiation of
erectile response by combination of prostaglandin E1 and rolipram in
the cat. Impotence Research, pp. 225-229, 1998.
Hellstrom WJG; Bivalacqua TJ; Kadowitz PJ
and Doherty PC: Type 3, 4 and 5 phosphodiesterase inhibitors influence penile
erection in the cat. Impotence Research, pp. 219-224, 1998.
Hellstrom WJG; Bivalacqua TJ, Champion HC
and Kadowitz PJ: The Role of Nitric Oxide on Penile Blood Flow and
Genitourinary Tract Function In: Nitric Oxide and the Regulation of the
Peripheral Circulation. Edited by Philip J. Kadowitz and Dennis B.
McNamara. Boston: Birkhauser, Biomedical Sciences, 1998.
Hellstrom WJG, Purohit SK:
Testosterone, Decreased. In: Penis, Trauma & Fracture. Edited by Leonard G. Gomella, M.D., and
Mark Dambro, M.D. Williams &
Wilkins, 1999.
Hellstrom WJG, Purohit, SK:
5-Minute Consult. In: Penis, Trauma & Fracture. Edited by Leonard G. Gomella, M.D., and
Mark Dambro, M.D. Williams &
Wilkins, 1999.
Ruiz-Deya G and Hellstrom
WJG: Management of Peyronie’s disease.
In: Male Sexual Dysfunction: Basic
Concepts, Diagnosis and Treatment.
(In press)
Purohit S and Hellstrom WJG: Impotence. In: Conn’s Current Therapy 2000. (In press)
INVITED CHAPTERS AND REVIEWS (cont’d)
Hellstrom WJG:
Treatment of Erectile Dysfunction (ED) In: Proceedings
of the 1st European Congress of Andrology. (In press)
BOOKS:
Hellstrom
WJG: Male Infertility and Sexual
Dysfunction. In: Textbook of Andrology.
Edited by Wayne J. G. Hellstrom.
Springer-Verlag: New York, April, 1997.
Hellstrom WJG: Handbook of Sexual Dysfunction. Edited by Wayne J. G.
Hellstrom. Allen Press: Lawrence,
Kansas. January 1999.
AUDIO and VIDEO TAPES:
Hellstrom WJG: Innovations in Laparoscopic Varicocelectomy, April 1992.
Hellstrom WJG: Current controversies in Andrology. April 1995.
Hellstrom WJG: Transurethral alprostadil: A new option in the treatment of
erectile dysfunction, Sept.1997.
Hellstrom WJG: New perspectives in the
management of BPH. April 7, 1998.
Hellstrom WJG: New treatments in male sexual dysfunction. June 1, 1999
ABSTRACTS:
Junemann KP; Lue
TF; Hellstrom WJG; Fournier GR and Tanagho EA: Hemodynamics of papaverine- and phentolamine-induced penile
erection in monkeys and dogs. AUA
Eightieth Annual Meeting. J Urology, 133:218A, 1985.
Hellstrom WJG; Bretan PN; Hricak H;
Schmidt RA and Tanagho EA: Urodynamic
sonography. AUA Eightieth Annual
Meeting. J Urology, 133:231A, 1985.
Hellstrom WJG; Kogan BA; Jeffrey RB and
McAninch JW: Ultrasound diagnosis of
prenatal hydronephrosis with normal amniotic fluid volumes. AUA Eightieth Annual Meeting. J
Urology, 133:355A, 1985.
Edwards MSB;
Kogan BA and Hellstrom WJG:
Urologic aspects of spina bifida/tethered cord syndrome. Congress of Neurological Surgeons Program
35th Annual Meeting 138, 1985.
Hellstrom WJG; Schmidt RA and Tanagho
EA: Neuromuscular dysfunction in
nonbacterial prostatitis. AUA Eightieth
Annual Meeting. J Urology, 133:176A (1985).
ABSTRACTS (cont’d)
Hellstrom WJG; Kogan BA; Jeffrey RB and
McAninch JW: The natural history of
prenatal hydronephrosis with normal amounts of amniotic fluid, pp.
268-270. In RM Pitkin and FJ Zlatnik
(Ed.) 1986 Year Book of Obstetrics
and Gynecology, Year Book Medical Publishers, Chicago, IL (1986).
Hellstrom WJG; Schachter J; Sweet RL and
McClure RD: Is there a role for
chlamydia trachomatis and genital mycoplasma in male infertility? AUA Eighty-First Annual Meeting. J
Urology, 135:162A, 1986.
Hellstrom WJG; Lilien DL; Hedgcock MW;
Gooding GAW and Narayan P: The benefits
of combined renal and bone scanning in prostate cancer. AUA Eighty-First Annual Meeting. J
Urology, 135:347A, 1986.
Hellstrom WJG; Overstreet JW; Moore S;
Samuels S; Lewis EL: Antisperm and
antibodies bind with different patterns to sperm of different men. Western Section AUA, 1987.
Hellstrom WJG; Deitch A; Lewis EL: The evaluation of male infertility by
aspiration DNA flow cytometry. Western
Section AUA, 1987.
Hellstrom WJG; Andrew JB; Katz DF;
Overstreet JW; Samuels SJ; Chang RJ; Lewis EL:
Does human sperm movement improve following varicocele repair? AFS, 1987.
Hellstrom WJG and Lewis EL: Improved design for microsurgery table. Western Section, AUA, 1988.
Hellstrom WJG; Overstreet JW; Samuels SJ;
Lewis EL: The relationship of
circulating antisperm antibodies to seminal antibodies in infertile men. Western Section, AUA, 1988.
Hellstrom WJG and Lewis EL: The contribution of aspiration
deoxyribonucleic acid-flow cytometry to the clinical evaluation of
vasovasostomy candidates. AUA, 1988.
Hellstrom WJG; Overstreet JW; Samuels SJ;
Lewis EL: The relationship of
circulating antisperm antibodies to sperm surface antibodies in infertile
men. AUA, 1988.
Deitch AD; Hellstrom
WJG; deVere White RW: Evaluation of
vasovasostomy candidates by DNA flow cytometry of testicular aspirates. Soc
Anal Cytol, 1988.
Hellstrom WJG; Samuels SJ; Waits SR;
Overstreet JW: Comparison of spermmar
and immunobead testing for IgG antisperm antibody binding. AFS, 1988.
Hellstrom WJG; Ghoniem GM; Stone AR;
Deitch AD; deVere White, RW: The
clinical application of aspiration DNA flow cytometry to paraplegics entering
an electroejaculation program. SMA,
1988.
Hellstrom WJG; Stone AR; Deitch AD;
deVere White RW: Evaluation of
electroejaculation patients by aspiration DNS flow cytometry. Intl
Conf Reprod Endocrin, 1988.
Hellstrom WJG; Tesluk H; Deitch AD;
deVere White RW: Comparison of flow
cytometry to routine testicular biopsy in male infertility. ASA, 1989.
ABSTRACTS (cont’d)
Hellstrom WJG; Lapeyrolerie J; Deitch AD;
deVere White RW: Screening
electroejaculation patients by aspiration DNA flow cytometry. Southeast Section of AUA, 1989.
Hellstrom WJG; Sikka SC; Deitch AD;
deVere White RW: Assessment of
neurologically impaired men for electroejaculation by DNA flow cytometry.
IVth Intl Congress of Andrology, 1989.
Hellstrom WJG; Stone AR; Deitch AD;
deVere White RW: The clinical
application of aspiration DNA flow cytometry to neurologically impaired men
entering an electroejaculation program.
AUA, 1989.
Deus FN; Hellstrom
WJG; Neal DE: A modified approach
for arterialization of the dorsal vein of the penis in vasculogenic
impotence. SMA, 1989.
Hellstrom WJG and Sikka S: The effect of pentoxifylline and caffeine on
motion parameters of cryopreserved sperm.
AFS, 1989.
Hellstrom WJG and Kaack BM: Optimum technique of testicular aspiration
for DNA flow cytometric analysis of spermatogenesis in primates (Papio
Anubis). AFS, 1990.
Sikka SC and Hellstrom
WJG: Application of a sperm
stimulation protocol to aspermic men entering an electroejaculation
program. AFS, 1990.
Sloane BB; Basadre
J; Hellstrom WJG: Evaluation and
treatment of gunshot wounds to the external genitalia. SES-AUA, 1990.
Hellstrom WJG; McFarland CW; Thorneycroft
IH; Sikka SC: Evaluation of stimulated
cryopreserved sperm using hamster ova penetration assay. AUA, 1990.
Roberts J;
Gormus B; Harrison R; Xu K; Hellstrom WJG: Effect of M. Leprae on testicular functions in sooty
mangbey monkeys with experimental leprosy.
First Intl. Conf. on Pathogenesis of Mycobacterial Infections, 1990.
Hellstrom WJG: Anatomical and clinical evaluation of emissary vein valve
ablation. Fourth World Meeting on
Impotence. Symposium on Corpus
Cavernosum Revascularization, 1990.
Hellstrom WJG: Emissary vein valve ablation:
an adjunct to deep dorsal vein arterialization procedures. Western Section AUA, 1990.
Neal D; Walters
F; Hellstrom WJG: Cavernosal
antibiotic levels in penile prosthesis surgery. SMA, 1990.
Hellstrom
WJG;
Harrison R; Kaack B; Neal D: Absence of
short term gonadotoxicity in primate testes receiving shock wave therapy. AFS, 1990.
Sikka SC and Hellstrom
WJG: Trypsin damage to cavernosal
smooth muscle cells in culture as monitored by lipid peroxidation. J
Cell Biology, 111(5):305, 1990.
ABSTRACTS (cont’d)
Walters FP;
Frentz GD; Hellstrom WJG: Early
operative management of the fractured penis:
A review of ten cases. SES-AUA,
1991.
Salvatore FT;
Sharman GM; Hellstrom WJG:
Vacuum constriction devices (VCD) and the clinical urologist: Making an informed selection. SES-AUA, 1991.
Walters FP; Neal
DE; Rege AB; George WJ; Ricci MJ; Hellstrom WJG: Cavernosal tissue antibiotic levels in
penile prosthesis surgery. SES-AUA,
1991.
Hellstrom WJG; Kaack BM; Harrison RW;
Thomas R; Neal DE: Absence of long-term
gonadotoxicity in primate testes receiving extracorporeal shock wave
application. SES-AUA, 1991.
Hellstrom WJG; Wang R; Sikka SC: Platelet activating factor (PAF) stimulates
motion parameters of cryopreserved
human sperm. J Andrology, 12(1):56, 125, 1991.
Steele RH; Wang
R; Harrison RM; Hellstrom WJG:
The reproducibility of semen parameters and DNA histograms from
testicular aspirates in the cynomolgus monkey model. ASA, 1991.
Sikka SC and Hellstrom
WJG: Membrane lipid peroxidation in
cavernosal smooth muscle cells from impotent men. J Andrology, 12(1):30, 53,
1991.
Walters FP; Neal
DE; Rege AB; George WJ; Ricci MJ; Hellstrom WJG: Cavernosal tissue antibiotic levels in
penile prosthesis surgery. AUA, 1991.
Hellstrom WJG; Kaack BM; Harrison RW;
Thomas R; Neal DE: Absence of long-term
gonadotoxicity in primate testes receiving extracorporeal shock wave
application. AUA, 1991.
Hellstrom WJG; Wang R; Walker C; Sikka
SC: The detrimental effects of
electrical current on the motion parameters of normal sperm. AFS, 1991.
Wang R; Minkes
RK; Kadowitz PJ; Domer FR; Hellstrom WJG: Sodium nitroprusside (SNP) causes penile erection in the feline
model. J Andrology, 1992.
Sikka SC; Wang
R; Walker CF; Kukuy E; Hellstrom WJG:
Effect of temperature changes on human sperm motion during electrical
stimulation. ASA, 1992.
Wang R; Steele
RH; Hellstrom WJG: Radiologic
observations from a long-term study on partial left renal vein ligation in the
cynomolgus monkey. ASA, 1992.
Steele RH; Wang
R; Hellstrom WJG: Testicular
aspiration compared to testicular biopsy as assayed by DNA-flow cytometric
parameters in the cynomolgus monkey undergoing partial left renal vein
ligation. ASA, 1992.
Bell M; Sikka
SC; Clisham PR; Hellstrom WJG:
Time course studies of membrane cholesterol and motility changes in
fresh and cryopreserved human sperm.
ASA, 1992.
ABSTRACTS (cont’d)
Hellstrom WJG; Wang R; Kadowitz PJ; Domer
FR: Potassium channel agonists cause
penile erection in cats. SES-AUA, 1992.
Wang R; Minkes
RK; Bellan JA; Kadowitz PJ; Domer FR; Hellstrom WJG: A feline model for the study of novel
vasoactive agents which produce erections.
SES-AUA, 1992.
Lee B; Sikka SC;
Randrup ER; Villemarette P; Baum N; Hower JF; Hellstrom WJG: Standardization of penile blood flow
parameters in normal men using intracavernosal PGE1, visual sexual
stimulation and color flow doppler.
SES-AUA, 1992.
Hanson JA;
Shelburne PV; Hellstrom WJG:
Computerized management of resident surgical experience, case list collection, and clinical research: Development of a Macintosh database. SES-AUA, 1992.
Wang R; Steele
RH; Hellstrom WJG: Analysis of
semen parameters and DNA flow cytometric parameters in the cynomolgus monkey
undergoing partial left renal vein ligation.
SES-AUA, 1992.
Lapeyrolerie JC
and Hellstrom WJG: One stage
total penile reconstruction. AUA, 1992.
Lee B; Sikka SC;
Randrup ER; Villemarette P; Baum N; Hower JF; Hellstrom WJG: Standardization of penile blood flow
parameters in normal men using intracavernosal PGE1, visual sexual
stimulation and color flow doppler. AUA,
1992.
Hellstrom WJG; Wang R; Kadowitz PJ; Domer
FR: Potassium channel agonists cause
penile erection in cats. AUA, 1992.
Gormley G; Lewis
R; Lieber M; Hellstrom WJG and McConnell JD: Effects of Finasteride on semen carnitine (c ) fructose (f) and
prostate acid phosphatase (PAP). EAU
Congress in Geneva, Italy. July 1992.
Sikka SC; Kukuy
EL; Wang R; Hellstrom WJG:
Evaluation of cyclic GMP as mediator of cavernosal smooth muscle
relaxation following pharmacologically induced erections in cats. SSR, 1992.
Rajasekaran M;
Jayaprakasam R; Hellstrom WJG and Sikka SC: Spermicidal effect of an antifungal saponin obtained from a
tropical herb. ASPET, 1992
Sikka SC; Wang
R; Fussell EN; Kukuy E; Hellstrom WJG:
Morphological evaluation of human sperm after in-vitro stimulation by
electric current. AFS, 1992.
Bell M; Sikka
SC; Rajasekaran M; Clisham PR; Hellstrom WJG: The effect of hydrogen peroxide-induced membrane lipid
peroxidation on human sperm motility and viability. AFS, 1992.
Hellstrom WJG; Wang R; Bell M; Kukuy E;
Sikka SC: The application of
pentoxifylline (PTX) and platelet activating factor (PAF) as cryoprotective
agents in cryopreservation of human sperm.
AFS, 1992.
ABSTRACTS (cont’d)
Smith RW and Hellstrom
WJG: Management of nonpalpable
testicular lesion using intraoperative ultrasonography. SMA, 1992.
Weintraub MP and
Hellstrom WJG: Treatment of
obstructed ejaculatory ducts by transurethral resection. SMA, 1992.
Hellstrom WJG; Wang R; Mona M; Domer FR;
Roberts JA: Penile erections are
induced by nitric oxide in primates.
SES/AUA, 1993.
Candela JV; Neal
DE; Hellstrom WJG: Successful
preservation of potency after treatment of glans hyperemia following deep
penile vein revascularization surgery.
SES/AUA, 1993.
Wang R; Domer FR;
Kadowitz PJ; Hellstrom WJG:
Nitric oxide mediates penile erection in cats. SES/AUA, 1993.
Moreno T and Hellstrom
WJG: Evaluation and treatment of
gunshot injuries to the external genitalia.
SES/AUA, 1993.
Lee BR; Kaneko
K; Hellstrom WJG: Gadolinium-enhanced
magnetic resonance imaging of the penis.
SES/AUA, 1993.
Weintraub MP; De
Mouy E; Hellstrom WJG: Newer
modalities in the diagnosis and treatment of ejaculatory duct obstruction. SES/AUA, 1993.
Steele RH; Wang
R; Hellstrom WJG: Prevention of
varicocele formation by accessory vessel occurrence in the primate model. SES/AUA, 1993.
Smith RW;
Walters F; Sikka SC; Hellstrom WJG:
Cavernosal tissue levels of ciprofloxacin in penile prosthesis surgery
used to assess adequacy of antibiotic prophylaxis. SES/AUA, 1993.
Wang R; Sikka
SC; Veeraragavan K; Hellstrom WJG:
Effect of platelet activating factor (PAF) and pentoxifylline (PTX) on
sperm cAMP concentration, sperm viability and motion characteristics during
sperm cryopreservation. SES/AUA, 1993.
VandenBerg T;
Sikka SC; Hellstrom WJG: A
retrospective analysis of duplex doppler results with past medical history in
patients with erectile dysfunction.
SES/AUA, 1993.
Wang R; Sikka
SC; Kukuy EL; Rajasekaran M; Hellstrom WJG: cAMP concentration of human sperm after in-vitro stimulation by
electric current. ASA, 1993.
Wang R; Bell M;
Sikka SC; Hellstrom WJG: The
effect of pentoxifylline and platelet activating factor on sperm cAMP
concentrations and membrane lipid peroxidation in cryopreserved human
sperm. ASA, 1993.
Rajasekaran M; Hellstrom
WJG; Sikka SC: Morphological and
biochemical evaluations of a spermicidal saponin obtained from a tropical
herb. ASA, 1993.
ABSTRACTS (cont’d)
Sikka SC; Kukuy
EL; Wang R; Wilson R; Hellstrom WJG:
Flow cytometric analysis of mitochondrial activity in electrically
stimulated human sperm. ASA, 1993.
Hellstrom WJG; Wang R; Bell M; Sikka
SC: Role of platelet activating factor
(PAF) and pentoxifylline (PTX) as human sperm cryoprotectants. Vth International Congress of Andrology,
1993.
Hellstrom WJG; Candela JV; Neal DE: Successful preservation of potency after
treatment of glans hyperemia following deep penile vein revascularization
surgery. AUA, 1993.
Weintraub MP; De
Mouy E; Hellstrom WJG: Newer modalities
in the diagnosis and treatment of ejaculatory duct obstruction. AUA, 1993.
Wang R; Sikka
SC; Veeraragavan K; Hellstrom WJG:
Effect of platelet activating factor (PAF) and pentoxifylline (PTX) on
sperm cAMP concentration, sperm viability and motion characteristics during
sperm cryopreservation. AUA, 1993.
Sakamoto K;
Sikka SC; Hellstrom WJG:
Application of pentoxifylline stimulated cryopreserved sperm in the immunobead binding
assay. AUA, 1993.
Steele RH; Wang
R; Hellstrom WJG: Inhibition of
spermatogenesis secondary to testicular biopsy and natural prevention of
varicocele formation in the monkey model following partial left renal vein
ligation. AUA, 1993.
Hellstrom WJG; Bell M; Wang R; Sikka
SC: Effect of sodium nitroprusside
(SNP) on sperm motility, viability, and lipid peroxidation. AFS, 1993.
Bell M; Grimm D;
Hellstrom WJG: Relationship
between human sperm motility and lipid content. ASA, 1994.
Sikka SC;
Rajasekaran M; Hellstrom WJG:
Effect of pentoxifylline on free radical induced sperm damage. ASA, 1994.
Rajasekaran M; Hellstrom
WJG, Sparks RL; Sikka SC:
Electricity induced damage to human sperm in-vitro involves free radical
generation. ASA, 1994.
Rajasekaran M; Hellstrom
WJG; Kumar KS; Clark EP; Sikka SC:
Effect of a combined radioprotection regimen on male reproduction. ASA, 1994.
Lowentritt JE;
Kawahara K; Human LG; Hellstrom WJG; Domingue GJ: Bacteria as etiologic agents in
prostatodynia. SBUR, (AUA) 1994.
Hellstrom WJG: Antisperm antibody testing.
Society for the Study of Male Reproduction, SBUR, (AUA) May 1994.
Wang R; Mona M;
Roberts JA; Hellstrom WJG:
Tunica vaginalis sperm reservoir in a monkey model of vas deferens
obstruction. AUA, 1994.
ABSTRACTS (cont’d)
Ahuja S; Noles
KE; Rajasekaran M; Hellstrom WJG:
Stimulation of collagen production in an in-vitro model for Peyronie?s
disease. AUA, 1994.
Shoukry M;
Ghoniem GM; Abdel-Aziz F; Hellstrom WJG: Human vasal changes after vasectomy: in-vitro studies. AUA, 1994.
Hellstrom WJG and Mona M: Successful management of traumatic high-flow
internal pudendal artery - urethral fistula.
13th International symposium of Operative Andrology,
Budapest, Hungary. 1994.
Sofikitis N;
Miyagawa I; Zavos P; Mona M; Sikka S; Toda T; Terakawa N; Hellstrom WJG: Effects of smoking on testicular function,
semen quality, and sperm fertilizing capacity.
ASA, 1995.
Sikka S;
Rajasekaran M; Hellstrom WJG; Agarwal B: Curcumin (diferuloylmethane) decreases sperm motility without
affecting viability or membrane integrity.
ASA, 1995.
Shenassa B;
Sofikitis N; Simopoulo D; Sikka S; Miyagawa I; Hellstrom WJG: Alterations in cat sperm acrosin during
epididymal passage. ASA, 1995.
Shenassa B;
Sofikitis N; Miyagawa I; Hellstrom WJG, Sikka S: Effects of cotinine on sperm hyperactivation
and acrosomal integrity. ASA, 1995.
Sofikitis N;
Miyagawa I; Zavos P; Sikka S; Koutselinis A; Mourtzinis D; Stiakakis I; Hellstrom
WJG: Calpain (CLP) modulators
regulate spermatozoal spectrin (SP) breakdown during epididymal sperm passage
(ESP). ASA, 1995.
Sikka S;
Rajasekaran M; Hellstrom WJG:
Free radical generation during electroejaculation of spinal cord injured
men. ASA, 1995.
Hellstrom WJG and Ahuja S: Prosthetic materials in surgery for
Peyronie's disease. SES-AUA, 1995.
Ahuja S; Krane
KN; Hellstrom WJG: Penile
prostheses in end stage renal disease and renal transplant patients. SES/AUA, 1995.
Ahuja S;
Rajasekaran M; Sikka S; Hellstrom WJG:
Stimulation of collagen production in an in vitro model for Peyronie's
disease. SES-AUA, 1995.
Candela JV;
Yadven M; Hellstrom WJG:
Three-piece inflatable penile prosthesis implantation: a comparison of the penoscrotal and
infrapubic surgical approaches.
SES-AUA, 1995.
Yamamoto Y; Ono
K; Sofikitis N; Miyagawa I; Rodriguez F; Sikka S; Hellstrom WJG: Sperm morphometry assay has high predictive
values for fertility potential in men with left varicocele (LV) after
varicocelectomy (VRM). AUA, 1995.
Yamamoto U;
Sofikitis N; Ono K; Miyagawa I; Rodriguez F; Shenassa B; Sikka S; Hellstrom
WJG: Kidney transplantation (KT)
restores the effects of chronic renal failure (CRF) on epididymal sperm
maturation process and nitric oxide synthase (NOS) activity. AUA, 1995.
ABSTRACTS (cont’d)
Ono K; Sofikitis
N; Yamamoto Y; Miyagawa I; Mona M; Hellstrom WJG, Mekras G: Seminal vesicles (Svs) can serve as sperm
reservoirs for IVF in men with bilateral ejaculatory duct obstruction
(EDO). AUA, 1995.
Mona M; Moreno
T; Hellstrom WJG: Management of
gunshot wounds to the male genitalia.
AUA, 1995.
Sikka S;
Rajasekaran M; Hellstrom WJG:
Oxidative stress and interleukins in seminal plasma during
leukocytospermia. AUA, 1995.
Hellstrom WJG; Shenassa B; Garrison E;
Wang R; Sikka S; Kadowitz P; Doherty P; Miyagawa I; Sofikitis N: Effect of combined erythropoietin (E) and
testosterone (T) therapy on the prostaglandin E1 erectile response
in the chronic renal failure feline model.
AUA, 1995.
Ono K; Sofikitis
N; Yamamoto Y; Miyagawa I; Sikka S; Hellstrom WJG: Orchiopexy reverses the detrimental effects
of unilateral experimental cryptorchidism in rats. AUA, 1995.
Sofikitis N;
Miyagawa I; Sharlip I; Hellstrom WJG; Mekras G; Mastelou E: Human pregnancies achieved by
intra-ooplasmic injections of round spermatid (RS) nuclei isolated from
testicular tissue of azoospermic men.
AUA, 1995.
Sofikitis N;
Miyagawa I; Ono K; Yamamoto Y; Rodriguez F; Hellstrom WJG; Kehayias
P: Detrimental effect of left
varicocele on the reproductive capacity of round spermatids (RSs). AUA, 1995.
Padma-Nathan H;
Bennett A; Gesundheit N; Hellstrom WJG; Henry D; Lue T; Morley J;
Peterson C; Prendergast J; Tam P; Teresi A; Place V and the VIVUS-MUSE Study
Group: Treatment of erectile
dysfunction by the medicated urethral system for erection (MUSE). AUA, 1995.
Peterson CA;
Bennett AH; Hellstrom WJG; Kaiser FE; Morley JE; Nemo KJ; Padma-Nathan
H; Place VA; Prendergast JJ; Tam PY; Tanagho EA; Todd LK; Varady JC and
Gesundheit N: Erectile response to transurethral alprostadil, prazosin, and
alprostadil/prazosin combinations. AUA,
1995.
Sikka S; Hellstrom
WJG; Sofikitis N; Peterson C; Hanamoto M; Place V: Effect of alprostadil and prazosin
(intraurethral delivery drugs) on human sperm.
ASRM, 1995.
Sikka S;
Rajasekaran M; Hellstrom WJG:
Evidence of a pro-inflammatory cytokine "GRO-?%" in seminal plasma of
infertile patients. ASRM, 1995.
Yadven M; Ahuja
SK; Hellstrom WJG: Testicular
prosthesis: pitfalls in management of the testicular mass and testicular
trauma. SMA, 1995.
Ahuja SK; Monga
M; Yadven M; Hellstrom WJG:
Sickle cell disease with high and low flow priapism treated with a
malleable penile prosthesis. SMA, 1995.
ABSTRACTS (cont’d)
Hellstrom WJG; Monga M; Thompson R; Cote
D; Harmon E: Reconstruction of a total
anterior urethral defect utilizing buccal mucosa. SMA, 1995.
Beltran A and Hellstrom
WJG: Technique for implantation of
the difficult repeat penile prosthesis.
SMA 1995.
Monga M;
Broderick GA; Hellstrom WJG:
Priapism in sickle cell disease:
The role of the penile prosthesis.
SES/AUA, 1996.
Hellstrom WJG; Cohen MS; Donatucci CF;
Gittelman MC; Knoll D; McRae JR; Nelson RP Jr.; Tuttle JP Jr.; Young PR; Zucker
IA; Gesundheit N; Place VA and the VIVUS-MUSE Study Group: Results of a multicenter, double-blind,
placebo-controlled trial of transurethral alprostadil in men with complete
erectile dysfunction. SES/AUA, 1996.
Wang R; Hellstrom
WJG; Sikka SC; Kadowitz P; Doherty P:
Penile Erection induced by transurethral administration of sodium
nitroprusside. ASA, 1996.
Wang R; Estrada
LS; Champion HC; Rajasekaran M; Sikka SC; Hellstrom WJG: Effect of lipopolysaccharide (LPS) and
interferon-? (IFN-?) on sperm motion in vitro.
ASA, 1996.
Wang R; Champion
HC; Sofikitis N; Hellstrom WJG; Doherty P: Comparison of transurethral
and intraerections in cats. ASA, 1996.
Champion HC;
Santiago JA; Wang R; Coy DH; Murphy WA; Kadowitz PJ; Hellstrom WJG: Adrenomedullin induces penile erection in
the cat. ASA, 1996.
Sikka SC;
Estrada LS; Champion HC; Wang R; Rajasekaran M; Hellstrom WJG:
Pro-inflammatory chemokine (IL-8) mediated effects on human sperm motility,
viability, and integrity. ASA, 1996.
Sikka SC;
Rajasekaran M; Hellstrom WJG: A
differential quantitative assessment of pro-inflammatory and anti-inflammatory
cytokines in leukocytospermia. AUA,
1996.
Wang R; Hellstrom
WJG; Sikka SC; Kadowitz P; Doherty P:
Penile erection induced by transurethral administration of sodium
nitroprusside. AUA, 1996.
Sikka SC;
Rajasekaran M; Hellstrom WJG:
Role of vitamin E and oxidative stress in the pathophysiology of diabetic
impotence. AUA, 1996.
Padma-Nathan H;
Auerbach SM; Barada JH; Burnett AL; Costabile RA; Ferrigni RG; Gillenwater JY; Hellstrom
WJG; Lue TF; Patterson DE; Romas NA; Shabisigh R; Young PR; Gesundheit N;
Spivack AP; Place VA and the VIVUS-MUSE Study Group: Multicenter, double-blind, placebo-controlled trial of
transurethral alprostadil in men with chronic erectile dysfunction. AUA, 1996.
Sikka SC; Human
LG; Baratta NA; Clisham PR; Hellstrom WJG: Bacteria and infertility. SSR, 1996.
ABSTRACTS (cont’d)
Sikka SC;
Rajasekaran M; Ghosh S and Hellstrom WJG: Characterization of seminal plasma oxidative stress in
genitourinary tract inflammation. ASRM, 1996.
Hellstrom WJG; Sikka SC; Peterson CA;
Cowley CL; Dzerk AM; Lee JW; Gesundheit N: Effect of transurethral alprostadil
on prostaglandin content of human ejaculate and on sperm motility. ISIR, 1996.
Nathan HP;
Bennett AH; Gesundheit N; Hellstrom WJG; Henry DC; Kaiser FE; Lue TF;
Peterson C; Prendergast J; Tam PY; Teresi AL; Todd LK; Place VA and the MUSE
Study Group: Transurethral therapy with
prazosin and/or alprostadil for men with erectile dysfunction. ISIR, 1996.
Hellstrom
WJG; Wang
R; Champion HC; Sofikitis N; Keeffer LK; Doherty PC: Novel nitric oxide donors induce penile erection in the cat. ISIR,
1996.
Champion HC;
Estrada LS; Wang R; Kadowitz PJ and Hellstrom WJG: Calcitonin gene
related peptide (CGRP) induces penile erection in the cat. ISIR, 1996.
Champion HC;
Estrada LS; Wang R; Baratta A; Rajasekaran M; Sikka SC and Hellstrom WJG: Effect of tumor necrosis factor (TNF"?) and interferon (IFN(?) on human sperm motility,
viability, and motion parameters. ASA,
1997.
Champion HC;
Wang R; Fitzgerald WE; Murphy WA; Coy DH; Kadowitz PJ and Hellstrom WJG: Proadrenomedullin n-terminal 20 peptide
(PAMP), a novel product of the adrenomedullin gene, induces penile erection in
the cat. ASA, 1997.
Champion HC;
Wang R; Murphy WA; Coy DH; Kadowitz PJ and Hellstrom WJG: Galanin induces penile erection in the
cat. ASA, 1997.
Rajasekaran M; Hellstrom
WJ and Sikka SC: Age-related alterations in plasma nitrite and nitrate
levels in impotent men. ASA, 1997.
Armstrong JS;
Rajasekaran M; Baratta A; Hellstrom WJG and Sikka SC: Antioxidant
capacity of seminal plasma compared to synthetic and biological free radical
scavengers. ASA, 1997.
Champion HC;
Wang R; Lambert DG; Kadowitz PJ and Hellstrom WJG: ATP(?S, a potent purinergic
agonist, induces penile erection in the cat.
ASA, 1997.
Wang R; Champion
HC; Sikka SC; Doherty P; Hellstrom WJG:
?"1-blockers enhance penile
erection effect of PGE1, in cats. ASA, 1997.
Hellstrom WJG; Wang R; Champion HC; Sikka
SC; Keefer LK and Doherty P: Penile erection induced by transurethral
administration of novel nitric oxide donors.
ASA, 1997.
Wang R; Da Ros
CT; Barcelos M; Champion H; Sikka SC and Hellstrom WJG: Do peptides stimulate sperm function? ASA, 1997.
Hellstrom WJG: Andrology, sexual dysfunction, and newer therapies for the
impotent man. ASA, 1997.
ABSTRACTS (cont’d)
Hellstrom WJG; Cohen MS; Donatucci CF;
Gittelman MC; Knoll LD; McRae JR and Nelson RP: Restoration of erectile
function by transurethral alprostadil improves quality of life for patients and
partners. SES/AUA, 1997.
VandenBerg TL;
Vincent MJ; Hellstrom WJG: Intraplaque verapamil injection for
Peyronie?s disease. SES-AUA, 1997.
Hellstrom WJG; Monga M; Harmon E: Complex
anterior urethral reconstruction using buccal mucosa. SES-AUA, 1997.
Hellstrom WJG; Cohen MS; Donatucci CF;
Gittelman MC; Knoll LD; McRae JR; Nelson RP: Restoration of erectile function
by transurethral alprostadil improves quality of life for patients and
partners. SES-AUA, 1997.
Rajasekaran M;
Chen I; Gierman J; Baratta NA; Hellstrom WJG; Sikka SC: Expression of calmodulin in primary culture
cells from human penile corpora cavernosa.
AUA, 1997.
Champion HC;
Wang R; Santiago JA; Murphy WA; Coy DH; Kadowitz PJ and Hellstrom WJG: Analysis of responses to Adrenomedullin and
calcitonin gene-related peptide in the feline erection model. AUA, 1997.
Lewis RW;
Brendler CB; Burnett AL; Ferrigni RG; Hellstrom WJG; Padma-Nathan H;
Romas NA and Shabsigh R; Stamey TA; Young PR; Stephens D; Peterson CA and
Gesundheit N: A comparison of transurethral alprostadil and alprostadil/prazosin
combinations for the treatment of erectile dysfunction. AUA, 1997.
Armstrong JS;
Rajasekaran M; Baratta NA; Hellstrom WJG and Sikka SC: A comparison of the Ros scavenging capacity
of human serum albumin and percoll: Implications in the preparation of human
sperm samples for assisted reproductive technology. AUA, 1997.
Hellstrom WJG; Sikka SC and Wang R: Does transurethral alprostadil affect the
concentration of prostaglandins in the human ejaculate or the viability and
motility of human sperm. ICA, 1997.
Hellstrom WJG; Wang R; Champion HC;
Estrada LS; Da Rosa C; Barcelos M and Sikka SC: Effect of novel peptides on human sperm motion, viability and
membrane integrity. ICA, 1997.
Hellstrom WJG; Gesundheit N; Hall M;
Peterson CA; Place VA; Stephens DE; Tam PY and Spivack AP: Long-term safety profile of transurethral
alprostadil for the treatment of erectile dysfunction. Canadian Urological Association, 1997.
Hellstrom WJG; Cohen MS; Donatucci CF;
Gittelman MC; Knoll LD; McRae JR and Nelson RP: Restoration of erectile function by transurethral alprostadil
improves quality of life for patients and partners. Canadian Urological Association, 1997.
Hellstrom WJG; Gesundheit N; Hall M;
Peterson CA; Place VA; Stephens DE; Tam PY and Spivack AP: Long-term safety profile of transurethral
alprostadil for the treatment of erectile dysfunction. SIU, 1997.
ABSTRACTS (cont’d)
Hellstrom WJG; Sikka SC and Wang R: Does transurethral alprostadil affect the
concentration of prostaglandins in the human ejaculation or the viability and
motility of human sperm? SIU, 1997.
Hellstrom WJG; Cowley C; Gesundheit N;
Hall M; Nemo KJ; Peterson CA; Stephens DE; Tam PY; Weldon KLM; Place VA and
Spivack AP: Report on the American
studies of MUSE: Transurethral
alprostadil for the treatment of erectile dysfunction: Long-term safety
profile. ESIR, 1997.
Hellstrom WJ: Stimulatory effects of Zaprinast, a type 5 PDE inhibitor, on
erection in the male cat. ESIR, 1997.
Sikka SC; Da Ros
C; Barcelos M; Champion HC; Wang R and Hellstrom WJG: Studies on human sperm motion: Effect of novel peptides. ASRM,
1997.
Labadie P and Hellstrom
WJG: Hematospermia: Clinical
directives. SMA, 1997.
Hellstrom WJG: Chair, Symposium - Male
Menopause: The role of hormone replacement therapy. SMA, 1997.
Hellstrom WJG: New advancements in the medical therapy of erectile
dysfunction. Knoxville Urological
Association Meeting, 1997.
Hellstrom WJG: Erectile Dysfunction Symposium: Contribution of transurethral
delivery of Alprostadil in the treatment of erectile dysfunction. Mexican Urological Association Meeting
(1997).
Hellstrom WJG: Emerging issues in recognition and treatment of testosterone
deficiency in males: Current findings on the relationship between testosterone
replacement and prostate disease. Mexican Urological Association Meeting
(1997).
Hellstrom WJG and the MUSE Group: Transurethral alprostadil for the treatment
of impotence. Milwaukee Urological
Association Meeting (1997).
Hellstrom WJG and the VIVUS Group:
Medical treatment of erectile dysfunction.
Korean Urological Association Meeting (1997).
Hellstrom WJG and the VIVUS Group: Contribution of transurethral delivery of
alprostadil to the treatment of erectile dysfunction. Indianapolis Urological Meeting (1997).
MUSE - The
American experience. United Kingdom
Urological Meeting (1998).
Champion HC;
Bivalacqua TJ; Wang R; Kadowitz PJ and Hellstrom WJ: [TYR1]-Nociceptin and nociceptin
have similar naloxone-insensitive erectile activity in the cat. ASA, 1998.
Bivalacqua TJ;
Champion HC; Wang R; Murphy WA; Coy DH; Bivalacqua WJ: Comparison of erectile responses to galanin
and galantide in the cat. ASA, 1998.
ABSTRACTS (cont’d)
Bivalacqua TJ;
Champion HC; Wang R; Murphy WA; Coy DH and Hellstrom WJ: Comparison of erectile responses to analogs
of adrenomedullin in the cat. ASA,
1998.
Sikka SC;
Ruiz-Deya G; Rajasekaran M; Hellstrom WJ: Interaction between superoxide dismutase (SOD) and cGMP on nitric
oxide mediated penile erection in rats.
ASA, 1998.
Rajasekaran M;
Armstrong JS; Baratta NA; Hellstrom WJ; Sikka SC: Nitric oxide mediated cytotoxicity to human
cavernosal smooth muscle cells in culture.
ASA, 1998.
Armstrong JS;
Rajasekaran M; Hellstrom WJ and Sikka SC: The effects of reactive oxygen species on human sperm metabolism
and motility: Implications for the role of intramitochondrial LDH-C4. ASA, 1998.
Hellstrom WJ: New perspectives in the management of BPH. Southern Medical Association and the
Department of Veterans Affairs, 1998.
Ruiz-Deya G and Hellstrom
WJ: Penile reconstruction, a big
challenge for reconstructive surgeons and a promising option for patients. SES-AUA, 1998.
Deya-Gilberto G;
Rajasekaran M; Aretker MW; Hellstrom WJ; Sikka S: Effect of superoxide dimutase (SOD) on cGMP
induced penile erection in rats.
SES-AUA, 1998.
Hellstrom
WJG, Wang R
and Doherty PC: Efficacy and safety of
transurethral alprostadil in post-prostatectomy patients with erectile
dysfunction. SES-AUA, 1998.
Ahuja SK; Case
J; Vincent M; Sikka SC and Hellstrom WJ: Intralesional injection of alpha interferon 2B in the treatment
of Peyronie’s disease. ASA, 1998.
Rajasekaran M;
Ruiz-Deya G; Hellstrom WJ and Sikka SC:
Prolactin inhibits the erectile response to vasoactive agents in rats. AUA, 1998.
Sikka SC;
Armstrong JS; Baratta AN; Rajasekaran M and Hellstrom WJ: Mechanisms of improved recovery of vital
human spermatozoa using human serum albumin separation. AUA, 1998.
Hellstrom WJ and the VIVUS Group: Endourethral application of prostaglandin in
erectile dysfunction (MUSE). 1st Balkan
Symposium of Andrology and 3rd Andrological Symposium of the Andrological
Center, 1998.
Hellstrom WJ, Peterson CA and Tam
P: One-year study of transurethral
alprostadil for erectile dysfunction: Efficacy, safety and satisfaction. 53rd Annual Meeting of Canadian Urological
Association, 1998.
Bivalacqua TJ;
Champion HC; Kadowitz PJ; Hellstrom WJG and Doherty PC: Potentiation of
erectile response by combination of prostaglandin E1 and rolipram in
the cat. ISIR, 1998.
Hellstrom WJG; Bivalacqua TJ; Kadowitz PJ
and Doherty PC: Type 3, 4 and 5 phosphodiesterase inhibitors influence penile
erection in the cat. ISIR, 1998.
ABSTRACTS (cont’d)
Hellstrom WJ, Peterson CA and Tam
P: One-year study of transurethral
alprostadil for erectile dysfunction: efficacy, safety and satisfaction. ISIR, 1998.
Rajasekaran M;
Sikka S; Hellstrom W; Doherty P and the Vivus Group: Evidence for the
presence of the type 4 phosphodiesterase (PDE4) in isolated human cavernosal
smooth muscle cells. ISIR, 1998.
Hellstrom WJ and the VIVUS Group: Stress induced reduction in human sperm
energy reserves: Role in male infertility?
AFS, 1998.
Hellstrom WJG; Bivalacqua TJ and Kadowitz
PJ: Type 3, 4, and 5 phosphodiesterase inhibitors influence penile erection in
the cat. AFS, 1998.
Bivalacqua TJ;
Champion HC; Kadowitz PJ and Hellstrom WJ: Potentiation of erectile
response by combination of prostaglandin E1 and rolipram in the
cat. AFS, 1998.
Rajasekaran M;
Sikka S; Hellstrom W and Doherty P: Evidence for the presence of the
type 4 phosphodiesterase (PDE4) in isolated human cavernosal smooth muscle
cells. AFS, 1998.
Hellstrom WJ: Point of View: Vasectomy, reversal or assisted
fertilization. 18th Brazilian Congress
of Human Reproduction, 1998.
Hellstrom WJ: Male infertility empirical
treatment: When to use it? 18th
Brazilian Congress of Human Reproduction, 1998.
Hellstrom WJ: Environmental and professional factors and male infertility. 18th Brazilian Congress of Human Reproduction,
1998.
Hellstrom WJ: Erectile dysfunction: Future prospects. 18th Brazilian Congress of Human Reproduction, 1998.
Drazek J and Hellstrom
WJG: Operative management of the fractured penis. SMA, 1998.
Ruiz-Deya G,
Jansen D and Hellstrom WJG: Penile reconstruction: Challenging for
reconstructive surgeon and satisfying for patients. SMA, 1998.
Shenessa B;
Davis R and Hellstrom WJG: Renal arteriovenous malformation: A urologic
dilemma. SMA, 1998.
Hellstrom WJG and Spivack AP: Does
renewed sexual activity increase cardiac morbidity: A meta-analysis of the
experience with transurethral alprostadil (MUSE). SES-AUA, 1999.
Reddy SK;
VandenBerg TL and Hellstrom WJG: Use of cadaveric pericardium in the
surgical therapy of Peyronie?s disease.
SES-AUA, 1999.
Champion HC;
Bivalacqua TJ; Wang R; Keefer LK; Doherty PC and Hellstrom WJG: The effect of
novel nitric oxide donors on penile erection in the cat. ASA, 1999.
ABSTRACTS (cont’d)
Bivalacqua TJ;
Champion HC; Purohit S; Kadowitz PJ; Doherty PC and Hellstrom WJG: The
influence of a type 5 cyclic GMP-specific phosphodiesterase inhibitor on penile
erection in the cat. ASA, 1999.
Armstrong JS,
Rajasekaran M, Hellstrom W and Sikka SC: Lack of involvement of a
membrane NADPH oxidase in superoxide anion generation by human
spermatozoa. ASA, 1999.
Sikka SC,
Armstrong JS, Human LG and Hellstrom W: Role of bacterial pathogens in
male factor infertility. ASA, 1999.
Wang R, Ye Y,
Champion HC, Sikka SC, Hellstrom WJG
and Lewis R: Effect of nociceptin, a newly discovered peptide, on sperm
motion, viability and membrane integrity.
ASA, 1999.
Rajasekaran M,
Sikka SC, Hellstrom WJ and Monga M: Characterization of nitric oxide
metabolites in seminal plasma of infertile men. ASA, 1999.
Champion HC,
Bivalacqua TJ, Wang R, Keefer LK, Doherty PC and Hellstrom WJG: The
effect of novel nitric oxide donors on penile erection in the cat. ASA, 1999.
Bivalacqua TJ;
Doherty PC and Hellstrom WJG: Induction of penile erection by
intracavernosal and transurethral administration of zapinast and prostaglandin
E1. AUA, 1999.
Reddy SK;
VandenBerg TL and Hellstrom WJG: Use of cadaveric pericardium in the
surgical therapy of Peyronie’s disease.
AUA, 1999.
Bivalacqua TJ;
Purohit SK; Sresthadatta A; Glass JR; Rajasekaran M; Abdel-Mageed AB; Sikka SC
and Hellstrom: Potential role of nuclear factor-6B in the induction of
Peyronie’s-like condition in the rat.
AUA, 1999.
Purohit SK;
Bivalacqua TJ; Minor LC; Rajasekaran M; Abdel-Mageed AB; Sikka SC and Hellstrom
WJG: Increased collagen type I and
III fibers in the Peyronie’s disease rat model. AUA, 1999.
Hellstrom WJG; Concepcion RS; Dechet GJ;
Guay AT; Nehar A; O’Leary MP; Nemo KJ; Tam PY and Gesundheit N: Efficacy of
MUSE (Alprostadil) in patients with erectile dysfunction who failed ViagraÔ (Sildenadil) therapy: Results from a
multicenter post-marketing study. AUA,
1999.
Teloken C, Badalotti M, Bivalacqua T, Sikka S, andHellstrom
WJG: Effects of Sildenafil on
Motility and Viability of Human Spermatozoa.
ASRM 1999 Annual Meeting.
Sikka S, Armstrong JS, and Hellstrom WJG: The Role of LDHC-4 in Sperm Energy
Metabolism and Motility. ASRM 1999
Annual Meeting.
Sikka S,
Armstrong JS, and Hellstrom WJG:
Role of Protein Kinase C in Reactive Oxygen Species (ROS) Generation by
Human Spermatozoa. ASRM 1999 Annual
Meeting.
ABSTRACTS (cont’d)
Hellstrom WJG and Fuh VL: DHT suppression
with Finasteride, a type 2 5?-reductase inhibitor, at a 1 mg dose has no
adverse effects on bone, lipids, or semen in healthy young men. Canadian Urological Association. June 1999.
Sikka SC;
Armstrong JS and Hellstrom WJG: The role of LDHC-4 in sperm energy
metabolism and motility. ASRM,
September 1999.
Bivalacqua TJ,
Champion HC, Ignarro LF, Katowitz PJ, and Hellstrom WJG: Gene-transfer of endothelial nitric oxide
synthase to the penis augments erectile responses in the aged rat. Society for the Study of Impotence, October
1999.
Bivalacqua TJ,
Champion HC, Virani Y, Sikka SC, Kadowitz PJ, and Hellstrom WJG: Decreased erectile response and increased
iNOS expression in a rat model of Peyronie’s disease. Society for the Study of Impotence, October 1999.
Burger M,
Bivalacqua TJ, Sikka SC, and Hellstrom WJG: The effect of sildenafil on motility, viability, and membrane
integrity of human spermatozoa. Society
for the Study of Impotence, October 1999.
PRESENTATIONS:
Ultrasound
diagnosis of prenatal hydronephrosis.
Tenth Northern California Residents Seminar, University of California,
Davis. October 1983.
Ultrasound
diagnosis of prenatal hydronephrosis.
Western Section, AUA, Reno, Nevada.
July 1984.
Neuromuscular
dysfunction in nonbacterial prostatitis.
Eleventh Northern California Residents Seminar, Letterman Army Medical
Center. October 1984.
Urologic aspects
of the tethered cord syndrome. Western
Section - AUA, Anaheim, California.
July 1985.
Neuromuscular
dysfunction in nonbacterial prostatitis.
Western Section of AUA, Anaheim, California. July 1985.
Urodynamic
sonography. Western Section - AUA,
Anaheim, California. July 1985.
Hemodynamics of
papaverine and phentolamine-induced penile erection in monkeys and dogs. Western Section - AUA, Anaheim,
California. July 1985.
Priapism:
current concepts in diagnosis and treatment.
Twelfth Northern California Residents Seminar, University of California,
San Francisco, California. November
1985.
Is there a role
for chlamydia trachomatis and genital mycoplasma in male infertility? AUA, New York, New York. May 1986.
PRESENTATIONS (cont’d)
The benefits of
combined renal and bone scanning in prostate cancer. Western Section, AUA.
July 1986.
Is there a role
for chlamydia trachomatis and genital mycoplasma in male infertility? Western Section, AUA. Seattle, Washington. July 1986.
The evaluation
of male infertility by aspiration DNA flow cytometry. Western Section AUA, Kona, Hawaii. February 1987.
Antisperm
antibodies bind with different patterns to sperm of different men. Western Section, AUA, Kona, Hawaii. February 1987.
The evaluation
of male infertility by aspiration DNA-flow cytometry. Pacific Coast Fertility Society, Palm Springs, California. April 1987.
Antisperm
antibodies bind with different patterns to sperm of different men. AUA, Los Angeles, California. May 1987.
Does human sperm
movement improve following varicocele repair?
AFS, Reno, Nevada. September
1987.
Clinical applications
of DNA flow cytometry of testicular aspirates in evaluating male
infertility. ACS, San Francisco,
California. October 1987.
Clinical
applications of DNA flow cytometry of testicular aspirates in evaluating male
infertility. Sixth Annual Biomedical
Research Symposium, Davis, California.
October 1987.
Clinical
applications of DNA flow cytometry of testicular aspirates in evaluating male
infertility. Tulane University, New
Orleans, Louisiana. January 1988.
The relationship
of circulating antisperm antibodies to seminal antibodies in infertile
men. Western Section, AUA, San
Francisco, California. March 1988.
Improved design
for microsurgery table. Western Section
- AUA, San Francisco, California. March
1988.
The infertile
man who should be referred, what can be done.
CMA, Reno, Nevada. March 1988.
The contribution
of aspiration deoxyribonucleic acid-flow cytometry to the clinical evaluation
of vasovasostomy candidates. AUA,
Boston, Massachusetts. June 1988.
The relationship
of circulating antisperm antibodies to sperm surface antibodies in infertile
men. AUA, Boston, Massachusetts. June 1988.
Comparison of
spermmar and immunobead testing for IgG antisperm antibody binding. AFS, Atlanta, Georgia. October 1988.
PRESENTATIONS (cont’d)
The clinical
application of aspiration DNA flow cytometry to paraplegics entering an
electroejaculation program. SMA, New
Orleans, Louisiana. November 1988.
Evaluation of
electroejaculation patients by aspiration DNA flow cytometry. Intl. Conf. Reprod. Endocrin., Beijing,
China. November 1988.
Comparison of
flow cytometry to routine testicular biopsy in male infertility. ASA, New Orleans, Louisiana. April 1989.
Screening
electroejaculation patients by aspiration DNA flow cytometry. Southeast Section of AUA, Hilton Head, South
Carolina. April 1989.
Assessment of
neurologically impaired men for electroejaculation by DNA flow cytometry. IVth Intl. Congress of Andrology, Florence,
Italy. May 1989.
The clinical
application of aspiration DNA flow cytometry to neurologically impaired men
entering an electroejaculation program.
AUA, Dallas, Texas. May 1989.
Pentoxifylline
stimulates the movement characteristics of cryopreserved sperm. ACS, Atlanta, Georgia. October 1989.
A modified
approach for arterialization of the dorsal vein of the penis in vasculogenic
impotence. SMA, Washington, D.C. November 1989.
The effect of
pentoxifylline and caffeine on motion parameters of cryopreserved sperm. The AFS, San Francisco, California. November 1989.
Cadaveric
studies involving emissary vein ablation and its clinical application to dorsal
vein arterialization procedures for vasculogenic impotence. International Symposium of Operative
Andrology, Berlin, Germany. March 1990.
Optimum
technique of testicular aspiration for DNA flow cytometric analysis of
spermatogenesis in primates (Papio Anubis).
ASA, Columbia, South Carolina.
April 1990.
Application of
sperm stimulation protocol to aspermic men entering an electroejaculation
program. ASA, Columbia, South
Carolina. April 1990.
Evaluation and
treatment of gunshot wounds to the external genitalia. Southeastern Section of AUA, Palm Beach,
Florida. April 1990.
Optimum
technique of testicular aspiration for DNA flow cytometric analysis of spermatogenesis
in primates (Papio Anubis). Tulane
University Basic Science Research Day, New Orleans, Louisiana. April 1990.
PRESENTATIONS (cont’d)
Immunologic
aspects of subfertility in 1990.
Louisiana State Urological Society Annual Meeting, New Orleans,
Louisiana. April 1990
o
Non-surgical
management of impotence:
o
Hormonal
replacement
o
Intra-cavernosal
injection of pharmacologic agents
o
Vacuum
devices
o
Electroejaculation
technique
o
Penile
revascularization and total penile reconstruction.
Work-up
and treatment of male infertility.
Reproductive Endocrinology Update and Pelviscopy Workshop, New Orleans, Louisiana. May 1990.
Moderator
for Impotence and Infertility. 28th
Annual Meeting of the Society of University Urology Residents, New Orleans, Louisiana. May 1990.
Evaluation
of stimulated cryopreserved sperm using hamster ova penetration assay. AUA, New Orleans, Louisiana. May 1990.
Effect
of M. leprae on testicular functions in sooty mangbey monkeys with
experimental leprosy. First Intl. Conf.
on Pathogenesis of Mycobacterial Infections, Stockholm, Sweden. June 1990.
Anatomical
studies and early clinical evaluation of emissary vein valve ablation and
retrocoronal plexus ligation in deep dorsal vein arterialization procedures for
vasculogenic impotence. Fourth World
Meeting on Impotence, Symposium on Corpus Cavernosum Revascularization. Rio de Janeiro, Brazil. September 1990.
Emissary
Vein Valve Ablation: An adjunct to Deep
Dorsal Vein (DDV) arterialization procedures.
Western Section AUA, Monterey, California. October 1990.
SMA,
Nashville, Tennessee. October 1990.
o
Cavernosal
antibiotic levels in penile prosthesis surgery.
o
Moderator
for Panel Discussion on the evaluation and treatment of impotence
Standardization
of fine needle aspiration biopsy of human testes using DNA flow cytometry. ACS, San Francisco, California. October 1990.
AFS,
Washington, D.C. October 1990.
o
Moderator
for Session on Clinical Male Infertility.
o
Absence
of short term gonadotoxicity in primate testes receiving shock wave therapy.
New
techniques in sperm retrieval and sperm stimulation. Current Advances in Urology, New Orleans, Louisiana. December 1990.
Patient's
goal directed approach to evaluation and treatment of erectile
dysfunction. Current Advances in Urology,
New Orleans, Louisiana. December 1990.
The
clinical applications of electroejaculation technique. Biomedical graduate student lecture, New
Orleans, Louisiana. February, 1991.
PRESENTATIONS (cont’d)
Southeast
Section AUA, Atlanta, Georgia. March
1991.
o
Early
operative management of the fractured penis:
A review of ten cases.
o
Vacuum
constriction devices (VCD) and the clinical urologist: Making an informed selection.
o
Cavernosal
tissue antibiotic levels in penile prosthesis surgery.
o
Absence
of long-term gonadotoxicity in primate testes receiving extracorporeal shock
wave application.
Reproductive
disorders in the male. Reproductive
Endocrinology postgraduate course lecture, New Orleans, Louisiana. April 1991.
ASA. Montreal, Canada. April 1991.
o
Platelet
activating factor (PAF) stimulates motion parameters of cryopreserved human
sperm.
o
The
reproducibility of semen parameters and DNA histograms from testicular
aspirates in the cynomolgus monkey model.
o
Membrane
lipid peroxidation in cavernosal smooth muscle cells from impotent men.
Studies
on sperm motility; biological and clinical applications. Louisiana Urological Association Annual
Meeting, Lake Charles, Louisiana. May
1991.
AUA,
Toronto, Canada. June 1991.
o
Cavernosal
tissue antibiotic levels in penile prosthesis surgery.
o
Absence
of long-term gonadotoxicity in primate testes receiving extracorporeal shock
wave application.
Sperm
stimulation techniques; and current therapy of the azoospermic patient;
Visiting Professor, Department of Urology, University of Connecticut. Farmington, Connecticut. July 1991.
The
detrimental effects of electrical current on the motion parameters of normal
sperm. AFS, Orlando, Florida. October 1991.
Characterization
of membrane associated changes in diabetic impotence. SBUR Fall Symposium, Rochester, Minnesota. November 1991.
Patient
sexual satisfaction after penile implant with Duraphase and 3-Piece Inflatable
Penile Prostheses. Kimbrough,
Baltimore, Maryland. December 1991.
International
Symposium of Operative Andrology, Istanbul, Turkey. March 1992.
o
Making
an informed decision on which vacuum constriction device (VCD) to prescribe.
o
Laparascopic
varicocelectomy
PRESENTATIONS (cont’d)
Annual
Meeting, Bethesda, Maryland. March
1992.
o
Sodium
Nitroprusside (SNP) causes penile erection in the feline model. ASA.
o
Radiologic
observations from a long-term study on partial left renal vein ligation in the
cynomolgus monkey.
o
Testicular
aspiration compared to testicular biopsy as assayed by DNA-flow cytometric
parameters in the cynomolgus monkey undergoing partial left renal vein
ligation.
o
Time
course studies of membrane cholesterol and motility changes in fresh and
cryopreserved human sperm.
o
Moderator
for session on Sperm Biology.
o
Effect
of temperature changes on human sperm motion during electrical
stimulation.
Louisiana
State Urological Meeting, Shreveport, Louisiana. March 1992.
o
Innovations
in laparoscopic varicocelectomy.
o
Standardization
of penile blood flow parameters in normal men using intracavernosal PGE1,
visual sexual stimulation and color flow Doppler.
o
One
stage total penile reconstruction
Southeast
Section AUA, Charlotte, North Carolina.
April 1992.
o
Potassium
channel agonists cause penile erection in cats.
o
Standardization
of penile blood flow parameters in normal men using intracavernosal PGE1,
visual sexual stimulation and color flow Doppler.
o
A
feline model for the study of novel vasoactive agents which produce erections.
o
Computerized
management of resident surgical experience, case list collection, and clinical
research: Development of a Macintosh database.
o
Innovations
in laparoscopic varicocelectomy.
o
Analysis
of semen parameters and DNA flow cytometric parameters in the cynomolgus monkey
undergoing partial left renal vein ligation
Visiting
Professor at First National Congress of Urology, Guatemala City,
Guatemala. April 1992.
o
Evaluation
and treatment of male infertility: new
techniques in sperm retrieval and sperm stimulation.
o
Patient's
goal-directed approach to evaluation and treatment of erectile dysfunction.
o
Laparoscopic
varicocelectomy; Innovations in laparoscopic varicocelectomy
AUA,
Annual Meeting, Washington D.C. May
1992.
o
One
stage total penile reconstruction.
o
Standardization
of penile blood flow parameters in normal men using intracavernosal PGE1,
visual sexual stimulation and color flow doppler.
o
Innovations
in laparoscopic varicocelectomy.
o
Characterization
of membrane associated changes in diabetic impotence.
o
The
effect of Finasteride on semen production and sexual function in normal
males.
Evaluation
of cyclic GMP as mediator of cavernosal smooth muscle relaxation following
pharmacologically induced erections in cats.
SBUR 1992 Annual Meeting, Washington D.C. May 1992.
PRESENTATIONS (cont’d)
Development
of new vasoactive drugs for pharmacologic evaluation. First Annual Health Science Associate Genitourinary Research
Conference, West Point, Pennsylvania, October 1992.
The
application of pentoxifylline (PTX) and platelet activating factor (PAF) as
cryoprotective agents in cryopreservation of human sperm. AFS, Annual Meeting, New Orleans, LA,
November 1992.
SMA
Annual Meeting, San Antonio, Texas, November 1992.
o
Management
of nonpalpable testicular lesion using intraoperative ultrasonography.
o
Treatment
of obstructed ejaculatory ducts by transurethral resection.
Visiting
Professor, Long Island Jewish Medical Center, New Hyde Park, New York. December 1992.
Andrology
for today and tomorrow. General Surgery
Grand Rounds, Tulane Medical Center, New Orleans, Louisiana. December 1992.
Medical
Grand Rounds, Veterans Administration Hospital, New Orleans, Louisiana. February 1993.
o
Moderator,
BPH Symposium.
o
Hormonal
Therapy for BPH.
The
use of prosthetic materials in the surgical management of Peyronie's disease.
International Conference on Peyronie's Disease, Bethesda, Maryland. March 1993.
Southeast
Section AUA, Nashville, Tennessee.
April 1993.
o
Penile
erections are induced by nitric oxide in primates.
o
Successful
preservation of potency after treatment of glans hyperemia following deep
penile vein revascularization surgery.
o
Nitric
oxide mediates penile erection in cats.
o
Evaluation
and treatment of gunshot injuries to the external genitalia.
o
Gadolinium-enhanced
magnetic resonance imaging of the penis.
o
Newer
modalities in the diagnosis and treatment of ejaculatory duct obstruction.
o
Prevention
of varicocele formation by accessory vessel occurrence in the primate
model.
o
Cavernosal
tissue levels of ciprofloxacin in penile surgery used to assess adequacy of
antibiotic prophylaxis.
o
Effect
of platelet activating factor (PAF) and pentoxifylline (PTX) on sperm cAMP
concentration, sperm viability and motion characteristics during sperm
cryopreservation.
o
A
retrospective analysis of duplex doppler results with past medical history in patients
with erectile dysfunction.
American
Society of Andrology, Tampa, Florida.
April 1993.
o
CAMP
concentration of human sperm after in-vitro stimulation by electric current.
o
The
effect of pentoxifylline and platelet activating factor on sperm cAMP concentrations
and membrane lipid peroxidation in cryopreserved human sperm.
o
Flow
cytometric analysis of mitochondrial activity in electrically stimulated human
sperm.
PRESENTATIONS (cont’d)
Role
of platelet activating factor (PAF) and pentoxifylline (PTX) as human sperm
cryoprotectants. Vth International
Congress of Andrology, Tokyo, Japan.
May 1993.
AUA,
San Antonio, Texas. May 1993.
o
Successful
preservation of potency after treatment of glans hyperemia following deep
penile vein revascularization surgery.
o
Newer
modalities in the diagnosis and treatment of ejaculatory duct obstruction.
o
Effect
of platelet activating factor (PAF) and pentoxifylline (PTX) on sperm cAMP
concentration, sperm viability and motion characteristics during sperm
cryopreservation.
o
Application
of pentoxifylline stimulated cryopreserved sperm in the immunobead binding
assay.
o
Inhibition
of spermatogenesis secondary to testicular biopsy and natural prevention of
varicocele formation in the monkey model following partial left renal vein
ligation.
American
Urological Association Postgraduate Program, Atlanta, Georgia. September 1993.
o
Impotence: therapeutic options.
o
Immunological
infertility: fact or fiction
o
Diagnosis
and therapy of male genital tract infections.
(The role of infection in infertility)
Effect
of sodium nitroprusside (SNP) on sperm motility, viability and lipid
peroxide. American Fertility
Society. October 1993.
6th
Annual Advances in Urology Conference, Orlando, Florida. January 1994.
o
Evaluation
and management of erectile dysfunction.
o
Evaluation
and treatment of male infertility
American
Society of Andrology Annual Meeting, Springfield, Illinois. March 1994.
o
Relationship
between human sperm motility and lipid content.
o
Effect
of pentoxifylline on free radical induced sperm damage.
o
Effect
of sodium nitroprusside on human sperm function.
o
Electricity
induced damage to human sperm in-vitro involves free radical generation.
o
Effect
of a combined radioprotection regimen on male reproduction.
Successful
management of traumatic high-flow internal pudendal artery - urethral
fistula. 13th International
Symposium of Operative Andrology, Budapest, Hungary. March 1994.
Update
on current management of the infertile male.
Invited Speaker, Al-Salaam Hospital, Jeddah, Saudi Arabia. March 1994.
Antisperm
antibody testing. Invited Speaker,
Society for the Study of Male Reproduction, (SBUR, AUA) San Francisco,
California. May 1994.
Bacteria
as etiologic agents in prostatodynia.
Society for Basic Urologic Research Annual Meeting, (AUA), San
Francisco, California. May 1994.
PRESENTATIONS (cont’d)
American
Urological Association Annual Meeting, San Francisco, California. May 1994.
o
Tunica
vaginalis sperm reservoir in a monkey model of vas deferens obstruction.
o
Human
vasal changes after vasectomy: in-vitro
studies.
o
Stimulation
of collagen production in an in-vitro
model for Peyronie's disease.
International
Symposium H. Ellis, Sao Paulo, Brazil.
June 1994.
o
NPT
which is the real role on the evaluation of impotent men.
o
Why
and how to do vascular test.
o
What
I have to say about Peyronie's disease.
o
Auto-injection
for treatment of erectile dysfunction: state-of-the-art.
Current
diagnostic and treatment strategies for erectile dysfunction. Visiting Professor, Memphis Urologic Society
Annual Meeting, Memphis, Tennessee.
August 1994.
Visiting
Professor, American Urological Association Highlight Symposium, New Orleans,
Louisiana. August 1994.
o
Male
impotence.
o
Male
infertility.
Development
of an animal model for the study of vasoactive agents for erection. Visiting Professor, VIVUS, Palo Alto,
California. September 1994.
Visiting
Professor, Dalhousie University, Nova Scotia, Canada. October 1994.
o
Current
update on male infertility.
o
Diagnosis
and treatment of erectile dysfunction.
Current
diagnostic and treatment strategies for erectile dysfunction. Visiting Professor, University of
Mississippi, Jackson, Mississippi.
January 1995.
Visiting
Professor, Al-Salaam Hospital, Jeddah, Saudi Arabia. January 1995.
Sexual
dysfunction in spinal cord injury patients, 5th Annual Incontinence Update, New
Orleans, Louisiana. February 1995.
American Society
of Andrology Annual Meeting, Raleigh, North Carolina. April 1995.
o
Effects
of smoking on testicular function, semen quality, and sperm fertilizing
capacity.
o
Curcumin
(Diferuloylmethane) decreases sperm motility without affecting viability or
membrane integrity.
o
Alterations
in cat sperm acrosin during epididymal passage.
o
Effects
of cotinine on sperm hyperactivation and acrosomal integrity.
o
Calpain
(CLP) modulators regulate spermatozoal spectrin (SP) breakdown during
epididymal sperm passage (ESP).
o
Free
radical generation during electroejaculation of spinal cord injured men.
o
Moderator,
Session on Erectile Dysfunction
PRESENTATIONS (cont’d)
Southeastern
Section of AUA Annual Meeting, Lake Buena Vista, Florida. April 1995.
o
Prosthetic
materials in surgery for Peyronie's disease.
o
Penile
prostheses in end stage renal disease and renal transplant patients.
o
Stimulation
of collagen production in an in vitro model for Peyronie’s disease.
o
Three-piece
inflatable penile prosthesis implantation: a comparison of the penoscrotal and
infrapubic surgical approaches.
American
Urological Association Annual Meeting, Las Vegas, Nevada. April 1995.
o
Orchiopexy
restores the effects of unilateral experimental cryptorchidism on the
contralateral testicular testosterone concentration, temperature, blood flow,
intravascular volume, and microvessel miotic activity.
o
Sperm
morphometry assay has high predictive values for fertility potential in men
with left varicocele after varicocelectomy.
o
Kidney
transplantation restores the effects of chronic renal failure on epididymal
sperm maturation process and nitric
oxide synthase activity.
o
Seminal
vesicles can serve as sperm reservoirs for IVF in men with bilateral
ejaculatory duct obstruction.
o
Management
of gunshot wounds to the male genitalia.
o
Oxidative
stress and interleukins in seminal plasma during leukocytospermia.
o
Effect
of combined erythropoietin (E) and testosterone (T) therapy on the
prostaglandin E1 (PGE1) erectile response in the chronic
renal failure feline model.
o
Treatment
of erectile dysfunction by the medicated urethral system for erection (MUSE).
o
Human
pregnancies achieved by intra-ooplasmic injections of round spermatid (RS)
nuclei isolated from testicular tissue of azoospermic men.
o
Detrimental
effect of left varicocele on the reproductive capacity of round spermatids
(RSs).
Erectile
response to transurethral alprostadil, prazosin, and alprostadil/prazosin
combinations. 90th Scientific Session
of the American Urological Association, Las Vegas, Nevada. April 1995.
Diagnosis of
Impotence. Invited Speaker,
International Congress, Societe Belge d'Urologie. Ghent, Belgium. May 1995.
Visiting
Professor, Winthrop University School of Medicine, Mineola, New York. June
1995.
o
Peyronie’s
Disease.
o
Advances
in Assisted Reproductive Technologies in Andrology.
Invited Speaker,
IX Urology Actualization Course, Porto Alegre, Brazil. June, 1995.
o
Treatment
of localized prostate cancer:
Prevention of impotence.
o
Reconstructive
surgery of the penis, urethra, and bladder.
o
Update
on Peyronie's disease.
Erectile
response to transurethral alprostadil, prazosin, and alprostadil/prazosin combinations. 55th Annual Meeting and Scientific Session
of the American Diabetes Association, Atlanta, GA, June 1995.
PRESENTATIONS (cont’d)
SMA's “Focus on
the Male Patient,” Kiawah Island, South Carolina, July 1995.
o
An
overview on the diagnosis and treatment of male infertility.
o
Peyronie’s
disease - new insights into etiology and treatments for this bending enigma.
o
The
penis that does not work like it used to: Update on the diagnosis and treatment
of erectile dysfunction.
The infertile
male: Work-up and therapy. OB/GYN Grand Rounds, LSU Medical Center,
Shreveport, Louisiana. September 1995.
American Society
for Reproductive Medicine, Seattle, Washington. October 1995.
o
Effect
of alprostadil and prazosin (intraurethral delivery drugs) on human sperm.
o
Evidence
of a pro-inflammatory cytokine “GRO-?” in seminal plasma of infertile patients.
o
Genitourinary
inflammation and infertility. Round
table leader.
Issues in the
management of the complicated diabetic patient. Tulane University School of Medicine Continuing Medical Education
Seminar. November, 1995.
Southern Medical
Association Annual Meeting, Kansas City, Missouri. November, 1995.
o
Testicular
prosthesis: pitfalls in management of
the testicular mass and testicular trauma.
o
Sickle
cell disease with high and low flow priapism treated with a malleable penile
prosthesis.
o
Reconstruction
of a total anterior urethral defect utilizing buccal mucosa.
o
Technique
for implantation of the difficult repeat penile prosthesis.
o
Natural
history and guidelines for the evaluation of BPH. Chairman and Speaker, Symposium on BPH.
Moderator,
Symposium on penile enhancement, Southern Medical Association Joint meeting of
Plastic and Reconstructive Surgery and Urology. Kansas City, MO.
November, 1995.
Visiting Professor,
Cleveland Clinic Foundation, Cleveland, Ohio.
March 1996.
o
Treatment
options for obstructive azoospermia, sperm aspiration and in vitro
fertilization (micromanipulation) versus surgical reconstruction.
o
Varicocele
Management: Open operative versus angiographic
versus laparoscopic intervention.
Southeastern
Section of AUA, Las Croabas, Puerto Rico.
March, 1996.
o
Priapism
in sickle cell disease: The role of the
penile prosthesis.
o
Results
of a multicenter, double-blind, placebo-controlled trial of transurethral
alprostadil in men with complete erectile dysfunction.
o
Infertility,
Post Graduate Course.
Male
Infertility, Tulane School of Medicine, New Orleans, Louisiana. March, 1996.
PRESENTATIONS (cont’d)
American Society
of Andrology, Minneapolis, Minnesota.
April, 1996.
o
Penile
erection induced by transurethral administration of sodium nitroprusside.
o
Effect
of lipopolysaccharide (LPS) and interferon-? (IFN-?) on sperm motion in vitro.
o
Pro-inflammatory
chemokine (IL-8) mediated effects on human sperm motility, viability, and
integrity.
o
Comparison
of transurethral and intracavernosal administration of PGE1 to induce erections
in cats.
o
Adrenomedullin
induces penile erection in the cat.
American
Urological Association, Orlando, Florida.
May, 1996.
o
A
differential quantitative assessment of pro-inflammatory and anti-inflammatory
cytokines in leukocytospermia.
o
Penile
erection induced by transurethral administration of sodium nitroprusside.
o
Role
of vitamin E and oxidative stress in the pathophysiology of diabetic impotence.
o
Multicenter,
double-blind, placebo-controlled trial of transurethral alprostadil in men with
chronic erectile dysfunction.
VII World
Meeting on Impotence, San Francisco, CA.
November, 1996.
o
Effects
of transurethral alprostadil on prostaglandin content of human ejaculate and on
sperm motility.
o
Novel
nitric oxide donors can induce penile erections in the cat.
o
Calcitonin
gene related peptide (CGRP) induces penile erection in the cat.
o
Transurethral
therapy with alprostadil and alprostadil/prazosin combinations in men with
erectile dysfunction.
Characterization
of Seminal Plasma Oxidative Stress in Genitourinary Tract Inflammation. AFS, November, 1996.
SMA, Baltimore,
MD. November, 1996.
o
Symposium
on Testosterone Deficiency and Replacement Therapy. (Chairman).
o
Penile
Calciphylaxis.
Current
Diagnostic and Treatment Strategies for Erectile Dysfunction. CME:
Innovation in Management in Elderly Patients, New Orleans, LA. January 1997.
Andrology,
Chair: Sexual Dysfunction, Treatment of
Hematospermia and Urethritis. CME:
Primary Care Series, New Orleans, LA.
March 1997.
Restoration of
erectile function by transurethral alprostadil improves quality of life for
patients and partners. SES/AUA, Naples,
Florida. March 1997.
South Eastern
Section AUA, Naples, Florida. March
1997.
o
Intraplaque
verapamil injection for Peyronie’s disease.
o
Complex
anterior urethral reconstruction using buccal mucosa.
The newest
developments in the therapy of erectile dysfunction. Puerto Rican Urological Association, San Juan, Puerto Rico. March 1997.
PRESENTATIONS (cont’d)
American
Urological Association Annual Meeting, New Orleans, Louisiana. April 1997.
o
Expression
of calmodulin in primary culture cells from human penile corpora
cavernosa.
o
Analysis
of responses to adrenomedullin and calcitonin gene-related peptide in the
feline erection model.
o
A
comparison of transurethral alprostadil and alprostadil/prazosin combinations
for the treatment of erectile dysfunction.
o
A
comparison of the ROS scavenging capacity of human serum albumin and percoll:
Implications in the preparation of human sperm samples for assisted
reproductive technology.
o
Hidden
Microorganisms in abacterial prostatitis/prostatodynia.
6th
International Congress of Andrology, Salzburg, Austria. May 1997.
o
Does
transurethral alprostadil affect the concentration of prostaglandins in the
human ejaculate or the viability and motility of human sperm?
o
Effect
of novel peptides on human sperm motion, viability and membrane integrity.
Canadian Urological
Association, QuJbec, Canada. June 1997.
o
Long-term
safety profile of transurethral alprostadil for the treatment of erectile
dysfunction.
o
Restoration
of erectile function by transurethral alprostadil improves quality of life for
patients and partners.
Societe
Internationale d’Urologie 24th Congress, Montreal, Canada. September 1997.
o
Long-term
safety profile of transurethral alprostadil for the treatment of erectile
dysfunction.
o
Does
transurethral alprostadil affect the concentration of prostaglandins in the
human ejaculation or the viability and motility of human sperm?
Visiting
Professor - University of Texas Health Science Center at San Antonio,
Texas. Erectile Dysfunction: Diagnosis
and treatment - Endocrine/Diabetes Grand Rounds. San Antonio, Texas.
September 1997.
Invited Speaker
- Florida Urological Society Meeting.
Medical advances in the treatment of sexual dysfunction males. Tarpon Springs, Florida. September 1997.
The European
Society for Impotence Research Meeting, Madrid, Spain. October 1997.
o
Pre
Congress Teaching Course: Contribution of transurethral delivery of alprostadil
to the treatment of erectile dysfunction.
o
Report
on the American studies of MUSE:
Transurethral alprostadil for the treatment of erectile dysfunction:
Long-term safety profile.
o
Stimulatory
effects of Zaprinast, a type 5 PDE inhibitor, on erection in the male cat.
Chair - Update
on current Andrologic practice: Diagnosis, treatment and results. ASRM, Cincinnati, Ohio. October 1997.
PRESENTATIONS (cont’d)
American Society
for Reproductive Medicine, Cincinnati, Ohio.
October, 1997.
o
Studies
on human sperm motion: Effect of novel
peptides.
o
Effect
of adrenomedullin on human sperm motility, viability, and motion parameters.
SMA, Charlotte,
North Carolina. November 1997.
o
Hematospermia:
Clinical directives.
o
Chair,
Symposium - Male Menopause: The role of hormone replacement therapy.
Androgens and
male sexuality. The Urologic Perspective:
Androgen Advisory Board Meeting, Santa Fe, New Mexico. November 1997.
New advancements
in the medical therapy of erectile dysfunction. Knoxville Urological Association Meeting, Knoxville,
Tennessee. November 1997.
Erectile
Dysfunction Symposium: Contribution of transurethral delivery of Alprostadil in
the treatment of erectile dysfunction. Mexican Urological Association Meeting, Acapulco, Mexico. November 1997.
Emerging Issues
in Recognition and Treatment of Testosterone Deficiency in Males: Current
findings on the relationship between testosterone replacement and prostate
disease. Houston, Texas. November 1997.
Transurethral
alprostadil for the treatment of impotence.
Milwaukee Urological Association Meeting, Milwaukee, Wisconsin. December 1997.
Medical
treatment of erectile dysfunction.
Korean Urological Association Meeting, Seoul, Korea. December 1997.
Contribution of
transurethral delivery of alprostadil to the treatment of erectile
dysfunction. Indianapolis Urological
Meeting, Indianapolis, IN. December
1997.
MUSE - The
American experience. United Kingdom
Urological Meeting, Scotland, United Kingdom.
January 1998.
American Society
of Andrology, Long Beach, CA. March
1998.
o
[TYR1]-Nociceptin
and nociceptin have similar naloxone-insensitive erectile activity in the cat.
o
Comparison
of erectile responses to galanin and galantide in the cat.
o
Comparison
of erectile responses to analogs of Adrenomedullin in the cat.
o
Interaction
between superoxide dismutase (SOD) and cGMP on nitric oxide mediated penile
erection in rats.
o
Nitric
oxide mediated cytotoxicity to human cavernosal smooth muscle cells in culture.
o
The
effects of reactive oxygen species on human sperm metabolism and motility:
Implications for the role of intramitochondrial LDH-C4.
Visiting
Professor - Winthrop-University.
Medical management of erectile dysfunction. Long Island, New York.
April 1998.
PRESENTATIONS (cont’d)
Course Chair -
New perspectives in the management of BPH.
Southern Medical Association and Department of Veterans Affairs,
Birmingham, AL. April 1998.
Southeastern
Section of the AUA, Birmingham, AL.
April 1998.
o
Penile
reconstruction: a big challenge for
reconstructive surgeons and a promising option for patients.
o
Effect
of superoxide dimutase (SOD) on cGMP induced penile erection in rats.
o
Efficacy
and safety of transurethral alprostadil in post-prostatectomy patients with
erectile dysfunction.
o
Chair,
post-graduate course: Office evaluation and treatment of sexual dysfunction.
Andrology,
sexual dysfunction and the new therapies for the impotent man. Debuque Urological Society Meeting, Debuque,
Iowa. May 1998.
Visiting
Professor - University of South
Florida: New developments of
erectile dysfunction from the resident perspective. Tampa, Florida. May 1998.
New developments
in the treatment of erectile dysfunction.
Urological Conference, Baton Rouge, Louisiana. May 1998.
American
Urological Association Annual Meeting, San Diego, California. May 1998.
o
Intralesional
injection of interferon alpha 2b in the treatment of Peyronie’s disease.
o
Prolactin
inhibits the erectile response to vasoactive agents in rats.
o
Mechanisms
of improved recovery of vital human spermatozoa using human serum albumin
separation.
Erectile
dysfunction: Strategies for communication and management in primary care
speaker workshop. Chicago, Illinois.
June 1998.
Endourethral
application of prostaglandin in erectile dysfunction (MUSE). 1st Balkan Symposium of Andrology and 3rd
Andrological Symposium of the Andrological Center, Alexandroupolis, Greece. June
1998.
One-year study
of transurethral alprostadil for erectile dysfunction: Efficacy, safety and
satisfaction. CUA, Halifax, Nova
Scotia. June 1998.
Is there a place
now and will there be a place in the future for intraurethral therapy for
impotence? Mentor Workshop,
Fayetteville, Arkansas. July 1998.
ISIR, Amsterdam,
The Netherlands. August 1998.
o
Symposium
moderator: The aging male.
o
One-year
study of transurethral alprostadil for erectile dysfunction: efficacy, safety
and satisfaction.
Impotence
Symposium, Haifa, Israel. September
1998.
o
The
US experience on transurethral therapy.
o
How
varicocele causes hormonal imbalances.
PRESENTATIONS (cont’d)
American
Fertility Society, San Francisco, California.
October 1998.
o
Stress
induced reduction in human sperm energy reserves: Role in male infertility?
o
Roundtable
on Male Reproduction: Genitourinary tract inflammation and male infertility.
Hypogonadism:
The role of testosterone in erectile dysfunction. Westchester County Medical Center, Valhalla, New York. October 1998.
Brain and
Behavior: Sexual Dysfunction and Paraphilia - New Treatments in Male Sexual
Dysfunction. Tulane CME Seminar, New
Orleans, Louisiana. October 1998.
Visiting
Professor - Vancouver General Hospital Grand Rounds: UBC, Vancouver,
Canada. October 1998.
o
Update
on erectile dysfunction.
o
Management
of Peyronie’s disease: New medical therapies in erectile dysfunction.
New medical
therapies in erectile dysfunction.
Ocean Pointe Resort Hotel, Victoria, Canada. October, 1998.
The History -
Central Intake - Questionnaire Tools.
American College of Surgeons 1998 Clinical Congress, Orlando,
Florida. October 1998.
Advances in
Testosterone Replacement Therapy: The Cincinnati Urological Society,
Cincinnati. Ohio. November 1998.
Invited Speaker
- 18th Congresso Brazileiro De ReproduH~o Humana, Porto Alegre,
Brazil. November 1998.
o
Point
of View: Vasectomy, reversal or assisted fertilization
o
Empirical
Treatment: When to use it?
o
Environmental
and professional factors in male infertility
o
Erectile
dysfunction: A glance into the future
Invited speaker
- Brazilian Reproduction Meeting, Rio de Janeiro, Brazil. November 1998.
o
Alternative
techniques for sperm retrieval: PESA, MESA, TESA, TESE, electroejaculation.
o
Peyronie’s
disease: State of the art.
o
What
is important in the evaluation of infertile men?
Hypogonadism: When and how to treat the
androgen-deficient man. Mobile,
Alabama; Dayton, Ohio; and St. Louis, MO.
November 1998.
Symposium Chair
- Approaches to managing the older male patient with erectile dysfunction:
Treatment, monitoring and follow-up.
SMA, New Orleans, Louisiana.
November 1998.
When and how to
treat the androgen-deficient male.
Burbank, California. December
1998.
Grand
Rounds: Recognition and treatment of
testosterone deficiency in males.
Lafayette, Louisiana. December
1998.
PRESENTATIONS (cont’d)
Hormonal
replacement therapy. Suffolk County
Urological Association Meeting, Bayshore, New York. January 1999.
Medical
management of erectile dysfunction.
Michigan Urological Society Meeting, Detroit, Michigan. January 1999.
Visiting
Professor - Duke University Medical School.
Duke Tuesday Conference: Will
the basic sciences and clinical therapy of Peyronie’s disease remain in
Urology? Durham, North Carolina. February 1999.
Intralesional
therapies for Peyronie’s disease. CME
Development Meeting for Urologists.
Palm Springs, California. March
1999.
Southeastern
Section of the American Urological Association, Charleston, South
Carolina. March 1999.
o
Does
renewed sexual activity increase cardiac morbidity: A meta-analysis of the experience with transurethral alprostadil
(MUSE).
o
Use
of cadaveric pericardium in the surgical therapy of Peyronie’s disease.
Medical
Education Collaborative Symposium on Sexual Dysfunction: New frontiers in the diagnosis and treatment
of prostate diseases symposium. Erectile dysfunction in prostatic disease. Philadelphia, PA. March 1999.
American Society
of Andrology, Louisville, Kentucky.
April 1999.
o
Invited
speaker - Erectile dysfunction urologic aspects: Symposium I.
o
Role
of bacterial pathogens in male factor infertility.
o
Lack
of involvement of a membrane NADPH oxidase in superoxide anon generation by
human spermatozoa.
Medical
Education Collaborative Symposium.
Atlanta, Georgia. April 1999.
o
Developments
in the diagnosis and management of prostate disease.
o
New
frontiers in the diagnosis and treatment of prostate diseases: Erectile
dysfunction.
Invited speaker
- A road map for men’s health breakfast seminar: Is there such a thing as male
menopause? Hotel Inter-Contintental,
(sponsored by Tulane CME), New Orleans, LA.
April 1999.
Moderator - Oral
Podium Session I: Peyronie’s
disease. American Urological
Association Meeting, Dallas, Texas. May
1999.
PRESENTATIONS (cont’d)
Presenter -
American Urological Association Meeting, Dallas, Texas. May 1999.
o
Induction
of penile erection by intracavernosal and transurethral administration of
zapinast and prostaglandin E1.
o
Use
of cadaveric pericardium in the surgical therapy of Peyronie’s disease. AUA.
o
Potential
role of nuclear factor-6B in the induction of Peyronie’s-like condition in
the rat.
o
Increased
collagen type I and III fibers in the Peyronie’s disease rat model.
o
Efficacy
of MUSE (Alprostadil) in patients with erectile dysfunction who failed ViagraTM
(Sildenadil) therapy: Results from a
multicenter post-marketing study.
Invited speaker
- Treatment of hypogonadism in males.
Mayo Clinic, Scottsdale, Arizona.
May 1999.
Invited speaker
- AUA Meeting Update. Update on ED for
1999. The University of Kansas Medical
Center, Kansas City, Missouri. May
1999.
Invited speaker
- AUA Update 1999: Erectile dysfunction.
Kelsey’s, New Orleans, Louisiana.
May 1999.
Invited speaker
- Royal College of Surgeons of Thailand Annual Meeting. Pattaya, Thailand. July 1999.
o
Current
management of male infertility
o
Pathophysiology
and management of erectile dysfunction
Invited
Speaker: Jackson Hole Summer Urology
Conference. Teton Village,
Wyoming. August 1999.
o
Male
hormone deficiency and androgen replacement therapy.
o
Peyronie’s
Disease: New concepts in molecular
research.
o
Peyronie’s
Disease: Innovations in therapy.
o
Hematospermia: Diagnosis, evaluation, and clinical
relevance.
o
Erectile
Dysfunction: The pro’s and con’s of the new oral drugs.
o
Current
urologic management of the infertile man.
Society for the
Study of Impotence Annual Meeting, Boston, Massachusetts, October 1999.
o
The
Effect of Sildenafil on Motility, Viability, and Membrane Integrity of Human
Spermatozoa
o
Decreased
Erectile Response and Increased iNOS Expression in a Rat Model of Peyronie’s
Disease
o The Role of Protein Kiuase C in Reactive Oxygen Species (ROS) Generation By Human Spermatozoa Gene-Transfer of Endothelial Nitric Oxide synthase to the Penis Augments Erectile Responses in the Aged Rat
ASRM Annual
Meeting, Toronto, Canada, September 1999:
o
Effects
of Sildenafil on Motility and Viability of Human Spermatozoa
o
The
Role of LDHC-4 in Sperm Energy Metabolism and Motility
o
Role
of Protein Kinase C in Reactive Oxygen Species (ROS) Generation by Human Spermatozoa
PRESENTATIONS (cont’d)
Chair,
Roundtable Luncheon: New developments in the treatment of sexual
dysfunction. American Society of
Reproductive Medicine Annual Meeting, Toronto, Canada. September 1999.
Grand Rounds
Visiting Professor: Contemporary issues
in the management of male erectile dysfunction. Louisiana State University, Shreveport. September 1999.
Invited speaker
- Advances in therapy of erectile dysfunction.
American College of Clinical Pharmacological Annual Meeting, Kansas
City, MO. October 1999.